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Normal somatic cells have a limited proliferative capacity in vivo and in 
vitro, termed senescence and later, thought to contribute to molecular and 
cellular organismal aging. There are several studies that demonstrate the 
importance of the GH/IGF axis in longevity, aging and cellular senescence. One 
primary component of the IGF signaling involves IGFBP-3.   It is well 
documented that IGFBP-3 levels are significantly increased in senescent human 
diploid fibroblasts however IGFBP-3 function is not known in this system.  
Interestingly, Werner syndrome fibroblasts, commonly used as a model of 
cellular aging, have upregulated IGFBP-3 levels in young and late passage cells 
compared to age matched normal fibroblasts. It is known that suppression of p38 
MAPK activity in WS fibroblasts can reverse the senescence and promotes cell 
proliferation. As increased IGFBP-3 expression is associated with cellular 
senescence, and suppression of p38 MAPK can reverse senescence in WS 
fibroblasts, it is hypothesized that “IGFBP-3 can induce senescence, by 
activating the p38 MAPK signaling pathway.” Our studies demonstrate IGFBP-3 
and novel IGFBP-3R can induce senescence in young fibroblasts, while 
suppression of IGFBP-3 in pre-senescent fibroblasts, can delay the onset of 
replicative senescence.  We identified ROS accumulation in IGFBP-3/IGFBP-R-
induced senescent cells which we speculated may be signaling p38 MAPK 
activation.  Inhibition of ROS accumulation suppressed p38 signaling and 
prevented IGFBP-3/IGFBP-3R-induced senescence. To evaluate the sequence 
of activation we inhibited p38 activity prior to senescence induction.  Interestingly, 
p38 inhibition prevented IGFBP-3/IGFBP-3R-induced senescence, suggesting 
IGFBP-3 signals ROS induction which activates p38 signaling.  We next 
examined the significance of IGFBP-3R in IGFBP-3-induced senescence. 
Suppression of endogenous IGFBP-3R inhibits IGFBP-3-induced senescence.  
We aimed to identify a possible regulatory mechanism for IGFBP-3 upregulation.  
Using sequence analysis software we identified 3 possible highly conserved 
miRNA sequences aligned to IGFBP-3.  miR-19a appeared to have the most 
significant downregulated expression in late passage fibroblasts compared to 
early passage.  Furthermore, overexpression miR-19a in late passage cells, 
significantly decreased IGFBP-3 expression, suggesting miR-19a may silence 
IGFBP-3 expression in senescence.  Making a direct mechanistic connection 
between senescence and aging is significant and unraveling how IGFBP-
3/IGFBP-3R can induce senescence could prove beneficial in understanding the 
aging process.   
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Chapter 1 
Introduction and Literature Review 
 
1.1 Cellular senescence and aging 
It was originally believed that cells in vitro could proliferate indefinitely and 
maintaining cells in culture was a matter of identifying the proper conditions (Ben-Porath 
& Weinberg, 2005).  It was the work of Hayflick and Moorhead in the early 1960’s who 
initially demonstrated that despite, culturing conditions, cells cease to proliferate and 
enter a senescent state (Hayflick & Moorhead, 1961).  The term ‘senescence’ is defined 
as a series of cellular changes often associated with aging  and inducible by various 
signaling pathways leading to irreversible cell growth arrest (Campisi, 2008).  It is 
difficult to identify an exact definition of cellular senescence. The most widely accepted 
definition of senescence is an irreversible growth arrest triggered by, continuous 
telomere shortening with each cell replication, oxidative damaging agents, stress stimuli 
or cell cycle deregulations following overexpression of proto-oncogenes (Toussaint, et 
al , 2002). The complexity of senescence is revealed by the fact that different cell types 
can undergo senescence by multiple, divergent pathways. 
There are currently two classifications of senescence, replicative senescence 
and stress-induced premature senescence (SIPS).  Although different mechanisms are 
responsible for inducing either replicative senescence or SIPS, the phenotypic and 
genotypic changes associated with both are nearly indistinguishable from one another.  
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Even though senescent cells lose their proliferative capacity, they remain 
metabolically active and viable for extended periods of time in culture.  Senescent cells 
are characterized as being postmitotic and incapable of proliferating in response to 
mitogenic stimuli.  
One of themore well understood inducers for replicative senescence in normal 
cells, is significantly shortened telomeres, as most human somatic cells do not produce 
the telomere-synthesizing enzyme telomerase and consequently suffers telomere 
shortening with each round of DNA synthesis (Harley, et al., 1990 and Ferenac, et al., 
2005).  SIPS was originally identified when normal young cells exposed to various types 
of subcytotoxic  stress, such as UV radiation, reactive oxygen species, nutrient 
imbalances or suboptimal culture conditions could promote irreversible growth arrest, 
regardless of their remaining replicative lifespan (Ishikawa, 2006). The SIPS-like 
phenotype and telomere-dependent replicatively senescent cells share basic 
similarities, such as irreversible growth arrest and resistance to apoptosis, which are 
known to signal different pathways; yet, the ultimate result remains the same.  As 
summarized in Figure 1, senescence is a complex cellular phenomenon that can be 
induced by various signals to activate diverse signaling pathways, all of which ultimately 
lead to irreversible cell growth arrest.   
The phenotypic changes associated with replicative senescent cells are relatively 
indistinguishable from prematurely induced senescent cells. Cells exhibit decreased cell 
saturation density, increased cell surface and volume, and a distinct flat morphology.  
The morphological changes are attributed to an increasing size of the nucleus and  
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nucleoli, with an increase in the number and/or size of lysosomes, vacuoles and 
mitochondria (Busuttil, et al., 2004).  The fundamental morphological changes of 
senescent cells are well known to be associated  with cytoskeletal regulatory proteins, 
including  integrins, focal adhesion complexes, comprised of integrins beta-1, paxillin,  
focal adhesion kinase (FAK), small Rho GTPases, caveolin-1, actin stress fibers and Rb 
family proteins (Cho and Park, 2004).  The identification of ‘senescence-associated 
genes,’ that induce and/or maintain senescence has also been crucial in unmasking 
pathways involved in tumorigenesis (Campisi et al., 2003). 
A major limitation of studying cellular senescence is the lack of specific 
biomarkers that can distinguish senescent cells from quiescent or terminally 
differentiated cells. Currently, the presence of senescence associated beta-
galactosidase (SA--gal) activity is the most commonly used biomarker of senescence, 
resulting from residual lysosomal -galactosidase activity at pH 6.0 (Dimri, et al., 1995).  
Additional markers have been identified and fall into three broad categories: factors of 
signal transduction pathways involved in induction and/or maintenance of senescence, 
DNA-damage markers coincident with telomeres, and markers of focal heterochromatin 
(Dierick, et al., 2002).  A prominent characteristic of senescent cells is a diminished 
response to serum or growth factors. However, the underlying mechanisms for the 
hyporesponsiveness to mitogenic stimuli is not well understood (Dierick, et al., 2002).  
The limited mitotic lifespan of cells has been interpreted as a manifestation of 
cellular aging.  Senescent cells continually display a number of molecular changes 
observed during the process of aging in vivo (Campisi, et al., 1997; Campisi, et al., 
1996). For example, skin biopsy samples from elderly individuals compared to young 
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people shows increased SA--gal cells.  Ever since Hayflick and Moorhead first 
reported the limited replicative lifespan of dermal fibroblasts in culture, senescence has 
been used as a model for aging studies.  Some theories suggest that normal 
accumulation of the by-products of normal metabolism can be detrimental to cell 
function.  
One of the oldest theories proposes that aging results from a senescence 
phenotype generated by accumulation of point mutations, deficiencies of enzymes 
and/or mutations in protein synthesis leading to increase in faulty proteins (Orgel, 1963).  
DNA repair plays an important role in preventing senescence, and perhaps cells with 
inefficient DNA repair mechanisms may undergo senescence.  Several premature aging 
disorders result from mutations or deletions in genes that are responsible for producing 
DNA repair enzymes. The cause of senescence and its correlation to organismal aging 
are addressed at many levels; at the cellular level in particular there is substantial 
evidence for many different theories without  a distinct consensus.    
 
1.2 Molecular mechanisms of senescence 
1.2.1 p53, p21 and p16 signaling in cellular senescence:   
Despite the various stimuli that can induce senescence, the current belief is that 
both replicative and stress-induced senescence are dependent on two major signaling 
pathways, which includes the p53 and retinoblastoma (RB) tumor suppressor proteins , 
as well as the p16Ink4a ( from hereon, p16) (Zdanov, 2007). 
Under normal conditions retinoblastoma protein (Rb) binds to E2F transcription 
factors to prevent the induction of genes required for the completion of the cell cycle, 
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whereas the p53 transcription factor induces a number of genes that block proliferation 
(Beausejour, et al., 2003).   Rb must be hyperphosphorylated for cells to proceed to S 
phase of the cell cycle, and senescent cells display no phosphorylation of Rb regardless 
of growth factor stimulation (Beausejour, et al., 2003).   Under normal physiological 
conditions, p53 remains low, due to Mdm2-induced degradation.  p53 can be 
phosphorylated and activated by various kinases such as casein kinase, DNA-PK or 
ATM. p53 activation can lead to protein accumulation, posttranslational modifications 
and subcellular translocation to induce cell cycle arrest or apoptosis by a variety of 
pathways including IGF-1-AKT, Rb-E2F, and p38 MAPK.  DNA damage, chromosomal 
defects, telomere shortening, cellular hypoxia and oncogene overexpression are known 
to activate p53 and its downstream targets, specifically p21waf-1.  Both in vitro and in vivo 
experiments have repeatedly demonstrated that the anti-oncogenic function of p53 is 
mainly due to the ability to induce apoptosis or cell cycle arrest. The significance of the 
p53-p21 pathway in replicative senescence was first suggested when tumor-virus-
encoded oncoproteins that interfere with p53 function extend the replicative life span of 
human cells, essentially by allowing them to ignore signals from short dysfunctional 
telomeres (Itahana, et al., 2004).  Experimentally, inhibition of p53 function by 
expression of human papillomavirus type 16 EV6 or disruption of a key downstream 
effector p21 by homologous recombination can extend replicative life span. Although 
p21 down regulation is sufficient to extend lifespan, is not necessary, as expression of a 
dominant-negative mutant p53 can increase life span without decreasing p21 
expression (Beausejour, et al., 2003).   It was often believed that functional wild-type 
p53 was required for human fibroblasts to undergo replicative senescence. However, 
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more recent data has shown cells can undergo premature senescence independent of 
p53 signaling.  Even though p53 is one of the primary signals activated when telomere 
length significantly shortens.   
The second pathway believed to be crucial in cell cycle arrest is the activation of 
p16 signaling. CDK1/p16 is also responsible for regulating RB activity, yet the 
mechanism for cell cycle arrest is different from that of p53. Ectopic expression of 
telomerase does not protect cells from replicative senescence, suggesting p16 function 
is independent of telomere status (Kiyono, et al., 1998, and Rheinwald et al.,, 2002). 
The transcriptional regulation of p16 is complex and not well characterized.  p16 
expression is known to increase with age in normal tissues of humans, while  p16 is  be 
downregulated in mice subjected to caloric restriction, resulting in increased lifespan. 
Although many investigators report presenescent fibroblasts display upregulated p21 
mRNA and protein levels following p53 activation, several opposing reports 
demonstrate once cells enter a senescent state, levels of p21 return to normal. 
Furthermore, p16 mRNA and protein levels are known to  remain elevated following 
senescence induction, suggesting an irreversible second barrier of cell proliferation 
inhibition induced by p16 upregulation (Takahashi, et al., 2006 and Vaziri, et al., 1999). 
The regulation of cell cycle progression and/or inhibition by p53, p21 and p16 signaling 
pathways, has categorized these genes as ‘senescence-associated’ genes (SA-genes).  
  
1.2.2 Telomeres and cellular senescence:  
Telomeres are repeated TTAGGG DNA sequences that form essential protective 
structures at chromosomes ends; however, they cannot be fully replicated by 
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conventional DNA polymerase. Telomeres are maintained by a specialized RNA-
templated polymerase, telomerase reverse transcriptase (Allsopp, et al., 1992). The 
repeated DNA sequence forms a protective T-loop structure stabilized by telomere-
binding proteins (Griffith et al, 1999), thereby inhibiting chromosome ends from being 
recognized as DNA breaks and preventing their degradation or end-to-end fusions  (de 
Lange, 2002). Most mammalian somatic tissues lack telomerase and therefore can 
shorten telomeres by 50-200 bp with each replication.  As telomeres shorten they can 
be mistaken for damaged DNA and identified for repair or produce telomeric end 
fusions, both of which result in senescence induction.    
Although telomere shortening in replicative senescence is well documented, it is 
now widely accepted that replicative senescence is not exclusively triggered by 
telomere shortening nor does telomerase overexpression prevent senescence 
(Ferenac, et al., 2005).   Telomerase can be induced at very low levels during S phase, 
yet this activation is insufficient to prevent telomere shortening (Allsopp, RC, et al., 
1995).  Interestingly, telomerase is expressed in a larger number of cancer cells, which 
are known to acquire an ability to ignore or bypass senescence-induced signals to 
become fully malignant (Kim, et al., 1994).  While the causal role of telomere erosion in 
senescence has been firmly established, and the ability of telomerase to prevent 
senescence in normal human fibroblasts indicates senescence is a very complicated 
cell program mediated by multiple pathways and mechanisms (Bodnar et al, 1998). The 
senescence response observed independent of telomere length appears to depend on 
the cell type, signaling effector and the level of its activation or overexpression (Harely, 
et al., 1990).   
9 
 
 
1.2.3 Oxidative Stress and Free-radical theory of aging:    
A substantial amount of experimental evidence has shown intracellular reactive 
oxygen species (ROS) contribute to senescence and aging.  The free-radical theory of 
aging was first proposed over 50 years ago and has since been studied extensively in 
an effort to identify the benefits or detrimental effects of ROS to aging. The free radical 
theory proposes that normal aging is a consequence of random deleterious damage to 
tissues by oxidative stress produced as a by-product of normal metabolism.  Under 
normal conditions, approximately 2-3% of oxygen atoms are taken up by the 
mitochondria and not sufficiently reduced, thereby producing ROS, which include, 
superoxide ion, hydroxyl radicals and hydrogen peroxide.  ROS serve various cellular 
functions such as second messenger, anti-bacterial agent, aging accelerant and growth 
stimulants (Colavitti, et al., 2005).  To prevent ROS accumulation, enzymes that 
degraded ROS are upregulated, such as catalase and superoxide dismutase. Increased 
oxidative stress, chronic or acute, can induce premature senescence in vitro; however, 
the kinetics of the growth arrest is often dependent on the anti-oxidative capacity of the 
cells.  In depth studies in Drosophila and C.elegans indicate that overexpression of 
ROS degrading enzymes or mutations in certain genes that signal pathways to 
modulate ROS stress response can significantly prolong lifespan.  The exposure of cells 
to a variety of stresses, such as UV-irradiation, hyperoxia, H2O2, tert-butylhydroperoxide 
or ethanol triggers young normal human diploid fibroblasts to enter into a premature 
senescent state via different signaling pathways; however all stimuli involved significant 
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accumulation of ROS (Feippiat, et al., 2002). The stimuli and mechanisms involved in 
ROS production, and the downstream effects are complex and diverse (Figure 2). 
Cells are commonly maintained in culture at 20% atmospheric oxygen levels, 
which is well above oxygen to which cells are exposed in the human body at only 3%.   
Interestingly, normal cell cultures maintained in low oxygen environments have an 
increased proliferation capacity (Muller, 2009).  The biochemical characteristics of aged 
tissues are the consequences of an increase in their pro-oxidant state, suggesting that 
this state may affect the activity and function of key proteins that signal transduction 
pathways that regulate stress responses (Muller, 2009).    
Caloric restriction (CR) has been well studied to expand the life span of rodents 
and suppress the development of diverse age-associated disease such as cancer, 
diabetes and renal disease (Sun, et al., 2001).  One possible explanation for how CR 
extends life span is through alterations in oxidative damage/oxidative stress (Sun, et al., 
2001 and Richardson, et al., 2004).  CR mice are known to be more resistant to 
oxidative stress, as the activity of one or more major antioxidant enzymes have been 
reported to be significantly increased in tissue of CR rodents.  Although there is no 
overall trend in the expression of antioxidant enzymes with CR, it has been repeatedly 
demonstrated the CR can reduce the production of ROS in mitochondria isolated from 
various tissue of rodents (Bokov, et al, 2004).  
Several studies have proposed ROS production may lead to increased activation 
of p38 MAPK and consequently cellular senescence.  More specifically, a recent study 
evaluated the ROS-mediated p38 MAPK pathway activation in aged livers and the long- 
11 
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lived Snell dwarf mouse model (Hsiech and Papaconstantinou, 2006)  The longevity of 
Snell dwarf mice has been attributed to their resistance to oxidative stress (Hsiech and 
Papaconstantinou, 2006). The activation of p38 MAPK pathway by ROS production, is 
based on the ability of reduced Thioredoxin (Trx) to bind to and inhibit apoptosis 
stimulating kinase 1 (ASK1).  ROS production activates the dissociation of the Trx-
ASK1 complex, thereby increasing p38 MAPK activity (Hsiech and Papaconstantinou, 
2006).  The balance between free versus ASK1 regulates the level of p38 MAPK 
pathway activation (Hsiech and Papaconstantinou, 2006).  In addition, the levels of Trx-
ASK1 complex in young and aged dwarfs are higher than their age-matched controls.  
These results suggest ROS production may alter the ratio of ASK1 and Trx-ASK1, and 
subsequently increase the age-associated basal level of p38 MPAK activity (Hsiech and 
Papaconstantinou, 2006, Hsiech and Papaconstantinou, 2002 and Hsiech, et al., 2004).   
 
1.3 Werner Syndrome, model of in vivo aging 
In vitro studies of senescence have provided a wealth of information relevant to 
the in vivo processes of aging.  Senescent cells have long been postulated to contribute 
to normal human aging as a whole organism, as accumulation of senescent cells 
increases with age and senescent cells are known to contribute to age-associated 
pathologies at the cellular level. Several premature aging disorders have been identified 
in humans, such as Cockayne syndrome, Rothmund Thompson and Hutchinson 
Guilford progerias. The early onset of aging disorders in these patients is useful for 
studying the aging process.  Although these disorders have been characterized to be 
associated with single gene mutation, the biological consequences are vast.   One of 
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the most well characterized premature aging disorders is Werner syndrome (WS).  
Patients with WS, described as a segmental Progeroid syndrome, show the premature 
onset of many clinical features of aging and therefore provide a significant model of 
normal organismal aging (Davis, et al., 2007).  WS is a homozygous recessive disease 
manifested by a mutation in the WRN gene. WRN belongs to the RecQ family of DNA 
helicases that encodes the WRN protein, which shares a strong homology to DNA/RNA 
helicases.  Helicases regulate numerous DNA metabolic functions such as transcription, 
replication and DNA repair.  Dermal fibroblasts derived from individuals with inherited 
premature aging syndromes, such as Werner syndrome, have reduced replicative life 
span in vitro compared to unaffected persons at the same age, thereby presenting a 
potential in vivo model for studying possible in vitro effects.   
 
1.4 p38 MAPK signaling 
The mitogen-activated protein kinase (MAPK) pathway is comprised of proteins  
known to transduce a variety of external stimuli to elicit various cellular responses, such 
differentiation, inflammation, apoptosis or cell growth (Figure 2). In the mammalian 
system three major MAPK pathways have been characterized: 1-MAPK/ERK 2- 
SAPK/JNK and 3-p38 MAPK. Interestingly, the result of recent studies suggested a 
significant role for p38 MAPK signaling in the accelerated aging phenotype of WS 
fibroblasts in culture.  It has been demonstrated that upregulation of p38 MAPK 
activation leads to the stabilization of p21 and the senescence phenotype in vitro. WS 
fibroblasts treated with SB203580, a cytokine-suppressive anti-inflammatory drug which 
targets p38 activity reverses the aged morphology of young WS fibroblasts similar to 
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that observed in normal fibroblasts of the same donor age. In addition to increasing the 
life span and growth rate to within normal range, a reduction in p21 expression is 
observed after SB203580 treatment, suggesting p21 activation by p38 is an essential 
regulator (Davis, et al., 2007)  
mRNA and protein expression levels of various genes known to be upregulated 
in replicative and premature senescence have been examined WS fibroblasts in an 
effort to identify crucial genes that are be responsible for the senescence phenotype.  
Interestingly, IGFBP-3 mRNA levels are significantly upregulated in young and old WS 
fibroblasts compared to age matched normal fibroblasts (Murano, et al., 1991).  Other 
studies have demonstrated that stable expression of an activated form of mitogen 
activated protein kinase-kinase-kinase 6 (MKK6), a direct activator of the stress-induced 
p38 MAPK pathway, is sufficient for inducing features of senescence in normal young 
fibroblast (Zarubin, et al., 2005).  
 
1.5 The GH/IGF axis in aging:  
Signaling through the growth hormone/Insulin-like growth factor (GH/IGF) axis 
has long been known to play a major role in determining the rate of aging in variety of 
species. The GH/IGF signaling pathway is one of the most well conserved and most 
consistent processes of aging in organisms ranging from yeast to mammals (Longo and 
Finch, 2003).   Hormonal changes, controlled by the endocrine system, have long been 
studied as possible regulators in inducing cellular aging.  The levels of GH and its 
downstream target IGF-I are known to be significantly downregulated with increasing 
aging; yet restoring hormonal levels does not delay the onset or reverse the phenotype, 
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but can actually accelerate the process.  The mechanism or role of GH/IGF signaling is 
still widely debated. Some studies support an antioxidant protective role, while others 
suggest the mitogen effect causes decreased cellular proliferation.  In mammals, 
decreased or dysregulated GH/IGF-1 signaling encourages longevity. Longevity genes 
are classified into two categories, genes relevant to nutrient-sensing systems and genes 
associated with mitochondrial function or redox regulation.  
From a clinical perspective one of the most influential aspects of aging and 
longevity is caloric restriction.  It is widely accepted that caloric restriction retards the 
aging process in laboratory mice and rats by delaying the occurrence or complete 
prevention of a broad spectrum of age-associated pathophysiological changes 
(Goldstein, et al., 1993).  CR is known to suppress the GH/IGF-1 axis, further 
implicating the significance of this signaling pathway (Keyon, 2005). The 
characterization of redox regulation and mitochondrial function in CR is still unclear.  
The molecular pathways involved in the regulation of chronological lifespan have 
been identified in various organisms.  Longo and Finch (2003) have diagramed a 
conserved regulation of longevity in yeast, worms, and flies, demonstrating how the 
conserved glucose or insulin/IGF-I-like pathways down-regulate antioxidant enzymes 
and heat shock proteins, reduce the accumulation of glycogen or fat, and increase 
growth and mortality. Mutations that reduce the activity of these conserved pathways 
have been shown to extend longevity by simulating caloric restriction or more severe 
forms of starvation. The induction of stress-resistance genes is required for longevity 
extension in yeast and worms. In mice, IGF-I activates signal transduction pathways 
analogous to the longevity regulatory pathways in lower eukaryotes and increases 
16 
 
mortality (Itahana, et al., 2002). However, the intracellular mediators of lifespan 
extension in GH- or IGF-I-deficient mice are not entirely understood.  In humans, GH or 
IGF-I deficiencies caused by mutations or deletions can lead to dwarfism, obesity, and 
other adverse effects.  Mammals with stress resistance capabilities have reduced IGF-I 
signaling, while increased levels of IGF-1 have been associated with increased risk of 
cancer (Hursting, et al., 2003).  The effects of GH or IGF-1 deficiencies remain unclear 
with regard organismal aging and longevity.    
The IGFs were originally described as mediators of the effects of growth 
hormone on somatic growth.  The IGF system plays a critical role in integrating growth, 
development and lifespan determined by metabolic conditions, subsequently serving as 
endocrine, autocrine and paracrine stimulators of mitogenesis, survival and cellular 
transformation (Rudman, et al., 1990 and Stewart, et al., 1996). The IGF system is 
comprised of IGF-I, IGF-II, a family of transmembrane receptors including the IGF-I and 
IGF-II receptors, and insulin-like growth factor binding proteins (IGFBPs) (Walker, et al., 
2003) (Figure 3).   The IGFBP superfamily is comprised of high and low affinity IGF 
binding proteins. High-affinity IGFBPs are essential for regulating the bioactivity of IGFs, 
either in circulation or the immediate extracellular environment by prolonging their half-
lives and regulating the availability of free IGFs to interact with IGF receptors. Six high 
affinity binding proteins have been identified, cloned and sequenced, IGFBP-1 through 
6.  IGFBP-3 is the most abundant IGFBP in serum and is responsible for carrying 75% 
of IGF-I and IGF-II in the heterotrimeric ternary complex with an acid-labile subunit.  The 
ternary complex is acted upon by proteases, whereby IGF-1 is released and available 
for interaction with IGF-IR.  IGF-I activation of the IGF-IR can elicit diverse biologic  
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Figure 3:  Schematic diagram of IGF system. There are several constituents of the IGF 
system, including IGF-I , IGF-II, their respective receptors and insulin receptor. In addition, 
there are 6 high affinity binding proteins. IGFBP-3 binds IGF-1 in complex with acid labile 
subunit. 
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effects, such as cell proliferation and differentiation, increased metabolic activation, and 
cell survival via antiapoptotic pathways, depending on cell type (Walker, et al., 2003) 
 
1.6.5 IGFBP-3 signaling in senescence 
Although IGFBP-3 is the principal carrier of IGFs in circulation, it is also an 
important component to the GH/IGF axis, playing a role in autocrine and paracrine 
growth control and apoptosis. The interaction of IGFs and IGF-IR is well characterized. 
However, it is widely accepted that IGFBP-3 has distinct biological effects independent 
of the IGF-IGF-R axis.   Numerous reports indicate IGFBP-3 can exert its biologic 
actions through a specific cell surface receptor or by interaction with intracellular 
proteins (Firth and Baxter, 2002 and Jogie-Brahim, et al., 2005) (Figure 4).  The IGF-
independent actions of IGFBP-3 have revealed a large array of signaling proteins with 
links to cell cycle control and apoptosis (Oh, et al., 1993). First, IGFBP-3 is a well-
documented inhibitor of cell growth and/or promoter of apoptosis in human cancer cells, 
primarily through the attenuation of the IGF-/IGF-R interaction. However, it is now know 
that these bioactivities can occur by IGF-independent pathways (Blat, et al., 1989).  The 
IGFBP-3 promoter contains a p53 binding site that upregulates its transcription (Jogie-
Brahim, et al., 2005).   
Evidence suggests an interaction between IGFBP-3 and TGF- signaling 
pathways.  It has been demonstrated that IGFBP-3’s growth inhibitory signal may 
require an active TGF-signaling pathway and implicates Smad 2 and 3 in IGFBP-3 
signal transduction.  Furthermore, IGFBP-3 has been proposed as a functional ligand 
for the serine/threonine kinase type V TGF- receptor, which is characterized to inhibit  
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cell growth (Barger, et al., 2003).  These studies confirm and support IGFBP-3’s 
involvement in cell signaling pathways independent of IGF and the IGF-I receptor 
interactions. 
        Debacq-Chainiaux et al, (2008) identified IGFBP-3 upregulation when screening 
for senescence-associated genes following repeated exposure to sublethal 
concentrations of tert-butylhydroperoxide (t-BHP) and ethanol. Further analysis 
revealed TGF-1 mRNA levels were upregulated after senescence induction, and 
surprisingly, inhibition of TGF-1 suppressed IGFBP-3 upregulation after t-BHP or 
ethanol-induced premature senescence (Debacq-Chainiaux, et al., 2008).   Finally, 
suppression of IGFBP-3 by siRNA inhibited premature senescence induced by t-BHP or 
ethanol.  This group has previously published work showing many senescence-related 
genes are overexpressed in fibroblasts after exposure to a variety stress agents, 
including fibronectin, an essential extracellular matrix component in cell adhesion, 
cytoskeletal organization and mediation of external mitogenic signals (Debacq-
Chainiaux, et al., 2008).    
Caveolin-1 protein is known to be a major regulator of IGFBP-3 endocytosis 
following protein processing and secretion.  Interestingly, caveolin-1 is known to play a 
critical role in senescence-associated morphological changes by regulating focal 
adhesion kinase activity and actin stress fiber formation (Cho and Park, 2004).   The 
upregulation of caveloin-1 may be having a positive effect on the efficiency of IGFBP-3 
to be internalized following secretion and signaling senescence induction.   
Further evidence for a potential role of IGFBP-3 in in vivo aging has been 
demonstrated as gradually increasing IGFBP-3 levels were observed in rat liver 
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homogenates in correlation with increasing age (Keyon, et al., 2005).  Another 
supportive finding for the potential significance of IGFBP-3 in senescence was the 
unmasking of a novel transcriptional regulatory element, IGFBP-3 enhancer element 
(IEE). The IEE was identified in the 5' untranslated region of the IGFBP-3 gene and can 
differentially activate IGFBP-3 expression in senescent when compared to young 
fibroblasts. Site-directed mutagenesis within IEE abolished binding activity of an as yet 
to be indentified binding partner, selectively decreased IGFBP-3 promoter activity in 
presenescent cells, ultimately leading to inhibition of senescence.  This data suggests 
the IEE as being a positive transcription regulatory element that contributes to the up-
regulation of IGFBP-3 during cellular senescence (Lu, et al., 2005).  
Finally, Kim et al, (2007) suggest a potential role of IGFBP-3 in the senescence 
of human umbilical vein endothelial cells (HUVEC), as IGFBP-3 suppression inhibited 
senescence. Moreover, an inverse correlation with Foxo3a activity was indentified when 
overexpression of IGFBP-3 accelerated senescence, and downregulation of IGFBP-3 
by siRNA rescued the growth arrested induced by p53 overepxression (Kim, et al., 
2007).  Foxo3a belongs to the family of Forkhead transcription factors that appear to 
transcriptionally up-regulate antioxidant defenses, including superoxide dismutase and 
catalase (Kim, et al., 2007).   Foxo3a protein levels were increased in aged cells 
following IGFBP-3 knockdown. Downregulation of Foxo3a is known to accelerate 
senescence in human dermal fibroblasts, suggesting a possible relationship between 
IGFBP-3 and Foxo3a.  Furthermore, in cell culture, constitutive expression of Akt 
activity leads to leads to inhibition of Foxo3a transcriptional activity, resulting in a rise in 
intracellular ROS. This rise in ROS is known to induce a p53-dependent senescent 
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arrest.  Although the exact interaction between Akt phosphorylation and IGFBP-3 
remains unclear, is has been reported that IGFBP-3 can induce activity of cellular 
phosphate known to activate Akt signaling. 
 
1.7 IGFBP-3/IGFBP-3R axis  
To extend our understanding of the IGF-independent action of IGFBP-3, we 
initiated an investigation to identify an IGFBP-3 receptor (IGFBP-3R) using the yeast 
two-hybrid system and identified a cDNA not identified in the database representing a 
novel gene/protein designated Clone 4-33 (Ingermann, et al., 2010).  Genomic 
database analysis identified that the gene covered a segment of 9-kb and spanned 4 
exons on chromosome band16q13. The 4-33 cDNA encodes a predicted protein of 240 
amino acids (Ingermann, et al., 2010).  The protein sequence contains a cAMP-
dependent phosphorylation site, a single leucine-zipper motif, and a putative 
transmembrane domain near the C-terminus (Ingermann, et al., 2010). The existence of 
4-33 in the plasma membrane and its binding to IGFBP-3 but not to other IGFBPs 
suggested that 4-33 is a putative IGFBP-3R (Ingermann, et al., 2010). The IGF-
independent senescence inducing mechanism(s) of action of IGFBP-3 in fibroblasts has 
not been entirely elucidated; however, the identification of this novel IGFBP-3R 
suggests there may be an unidentified pathway signaling senescence.  Our laboratory 
has recently published the identification of this novel binding partner for IGFBP-3 
(Ingermann, et al., 2010). IGFBP-3R characterization and signaling mechanism has 
been described in a variety of cancer cells lines, showing apoptotic signaling by 
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activation of caspase signaling cascade (Ingermann, et al., 2010).  The function of this 
IGFBP-3R in normal cells remains to be investigated.  
 
1.8 Significance of research  
A growing body of evidence has demonstrated that IGFBP-3 is an important 
growth-suppressing factor in various cell systems through an IGF-dependent 
mechanism.  Recent studies have also revealed that IGFBPs may have specific 
biological effects in various cell systems, including fibroblasts, many of which are not 
mediated through interaction with IGFs (IGF-independent actions).  Studies from our 
laboratory and others have demonstrated that IGFBP-3 is upregulated in senescent 
fibroblasts and can induce premature senescence in early passage fibroblasts.  Upon 
replicative senescence in vitro, a significant upregulation of IGFBP-3 protein in the 
cultured medium is observed. Furthermore, several investigators have identified IGFBP-
3 to be upregulated at both the protein and mRNAs during replicative and premature 
senescence. IGFBP-3 mRNA expression levels are consistently elevated in both SIPS 
fibroblasts and from cells obtained from WS patients, regardless of patient age.  These 
data are suggestive of an adaptive or causal role for IGFBP-3 protein in the senescent 
growth arrest of human diploid fibroblasts. IGFBP-3-transfected fibroblasts display 
morphological changes; upregulated senescence-associated genes, and increased SA-
-gal staining.  The mechanism(s) for upregulation of endogenous IGFBP-3 in 
senescent human diploid fibroblasts and IGFBP-3 induced-senescence in early 
passage fibroblasts have yet to be entirely elucidated.  Since elevated IGFBP-3 mRNA 
and protein levels, along with increased p38 MAPK activity and ROS production, are all 
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upregulated in replicative and/or prematurely induced senescence, it is of interest to 
characterize the significance of the IGFBP-3/IGFBP-3R system in senescence and the 
aging process. Several studies have demonstrated IGFBP-3 upregulation following 
senescence induction; however, the specific biochemical/molecular mechanisms 
involved in IGFBP-3’s action have yet to be identified. We therefore hypothesize that 
this novel IGFBP-3/IGFBP-3R axis regulates senescence by activation of p38 MAPK 
signaling pathway following ROS accumulation (Figure 5).  
The presence of senescence-associated markers at sites of age-related 
pathologies has proven helpful in linking in vitro senescence with in vivo aging.  
Currently, the identification and quantification of senescent cells in vivo is possible, 
although the physiological consequences of senescent cells in vivo is only beginning to 
be understood.  Compelling data demonstrates a link between increasing rates of 
cellular senescence and accelerated aging.  The extent to which cellular senescence 
contributes to the natural life span of any particular species remains to be 
demonstrated. Establishing a link between cellular senescence and aging would 
inevitably provide a wealth of information towards identifying possible therapeutics for 
age-associated pathologies.  Identification of the pathways activated or suppressed in 
the induction of senescence will provide valuable insight into numerous molecular 
mechanisms believed to be protective or detrimental to organism survival. Therefore, 
unraveling the cellular senescence signaling pathway(s) is extremely vital and will 
undoubtedly advance this field of study.   
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Chapter 2 
Materials and Methods 
 
Cells Culture and lysates 
Human lung fibroblasts (HFL-1) (Manassas, Va, ATCC) were maintained in F-12 
nutrient media (Carsbald, Ca, Gibco) supplemented with 10% fetal bovine serum (FBS) 
(Gibco). AG003141 and AG00781 Werner Syndrome fibroblasts (WS) (Coriell Institute, 
Camden, NJ) were maintained in MEM (Sigma, St. Loius, Mo) and supplemented with 
2mM  L-glutamine and 10% FBS. BJ and BJ/hTERT fibroblasts were cultured in DMEM 
(Manassas, Va, Cellgro) medium supplemented with 10% fetal bovine serum 10% 
DMEM.  Cells were split in a 1:2 or 1:3 ratio depending on experiment using 0.05% 
trypsin-EDTA (Gibco). All cell cultures were incubated at 370C in 5% CO2 and 100% 
humidity.  Cells were lysed in HBSST (Hanks buffered with 0.035% sodium bicarbonate, 
0.5% Triton X-100, 1 mM Mg SO4 and 1mM CaCl2, ph 7.4) supplemented with Halt 
TM 
protease inhibitor  (Thermo Scientific). Cell lysates were cleared by centrifugation at 
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12,000 rpm for 10 minutes.  Totalprotein isolated in the supernatant was quantified 
using BCA-Protein Assay Kit (Pierce) and spectrophotometer analysis. 
 
Passage doubling 
Passage doubling was calculated using the equation: n = 3.32 (LOG UCY-log I ) 
+ x. n = final PD at the end of a given subculture, UCY = cell yield at a specific point, I = 
cell number used as an inoculum at the start of subculture, x = doubling level of the 
incoulum used to initiate the subculture being quantitiated.   
 
Chemicals and Reagents 
The following materials were purchased from Sigma Chemical (St. Loius, Mo): 
trypan blue solution, dimethlyformamide (DMF) and reduced L-glutathione. 
Glutaraldeyde and formaldeyde were purchase from Fisher Scientific.  p38 inhibitor 
SB203580 (4-[5-(4-Fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1H-imidazol-4-yl]pyridine) 
was purchased from Tocris Bioscience (Ellisville, Mo).  
Real-time RT-PCR.  
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Total RNA was extracted from cultures using a TRIzol (Invitrogen, Carlsbad, Ca) 
extraction technique as recommended by the manufacturer. Total RNA was reverse 
transcribed using ThermoScriptTM RT-PCR System (Invitrogen).  Quantitative PCR 
(qPCR) reactions assay contained 1x SYBR green PCR mastermix (Applied 
Biosystems, Carlsbad, Ca), 200 nM primers concentration. A hot start at 950C for 5 
minutes, followed by 40 cycles at 950C for 15 seconds and 650C for 1 minutes using a 
7900 HT Thermal cycler (Applied Biosystems).  Each sample was tested in duplicate or 
triplicate, as indicated in the text. Table 1 lists qPCR primers used.    
 
miRNA 
Total RNA was transcribed using miRNA specific primers, 34a, 19a or 381.  Pre-
miR precursor was purchased from Ambion (Carlsbad, Ca).  Cells were seeded at 65% 
confluency and trasnfected using siPORTTM Neo FXTM agent (Applied Biosystems) in 
10% serum containing media with pre-miRNA or FAM-labeled control precursors for a 
final 25nM concentration. Cell protein and mRNA levels were analyzed by qPCR or 
western blot, 60 hours following transfection.  
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Table 1: qPCR Primers 
2M For 5'-GTG CTC GCG CTA CTC TCT CT-3' 
  Rev 5'-TCA ATG TCG GAT GGA TGA AA-3' 
IGFBP-3 For 5'-CAG AGC ACA GAT ACC CAG AAC TTC-3‘ 
  Rev 5'-CAC ATT GAG GAA CTT CAG GTG ATT-3' 
p53 For 5'-CGA GTA CGA CCA GTG CTT CA-3' 
  Rev 5'-CTG GAC TTG CGA AAT CCT TC-3' 
p21 For 5'-GGA AGA CCA TGT GGA CCT GT-3’  
  Rev 5'-GGC GTT TGG AGT GGT AGA AA-3’ 
p16 For 5'-TGG ACC TGG CTG AGG AGC T-3‘  
  Rev 5'- GAC CTT CCG CGG CAT CTA T-3' 
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Western Blot Analysis and Quantitation  
Cells were washed in PBS and lysed in HBSST buffer.  Lysates were mixed with 
4x Sample preparation buffer (SPB, 125mM Tris pH 6.8, 4% SDS, 20% glycerol, 0.2% 
bromophenol blue) for 10 minutes at 950C with or without DTT.  Cell lysates were 
loaded into 5% stacking gel and 10, 12 or 14% SDS-PAGE gel run at 180V for 1 hour.  
Proteins were then transferred to PVDF membrane at 350 mAmps for 70 minutes.  Blots 
were blocked at room temperature for 1 hour in 1x TBS/0.05% Tween 20 with 5% non-
fact dried milk.  Primary antibodies were added in blocking buffer for 2% BSA. p53 
(#9282), phospho p38 (#9212) and total p38 (#9212) antibodies were purchased from 
Cell Signaling (Denver, Ma). Primary antibodies p21 (SC-756), p16 (sc-9968) and SOD-
1 (sc-11407) were purchased from Santa Cruz (Santa Cruz, Ca). An - tubulin antibody 
was purchased Sigma-Aldrich. Blots were washed 3 times in 1xTBS/ .05% Tween20 for 
5 minutes and incubated and rocked for 1 hour at room temperature with secondary 
antibodies conjugated to horseradish peroxidase, -rabbit (#7074) or -mouse (#7076) 
(Cell signaling).  An -goat (sc-2056) antibody was purchased from Santa Cruz.  Protein 
was detected by chemiluminescence reaction Western Lightning (Perkin Elmer, Covina, 
Ca) according to the manufacture’s instructors.  Quantitation was performed by 
densitometry analysis.   
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siIGFBP-3R generation     
Synthesis of siIGFBP-3R-Double-stranded RNAs targeting IGFBP-3R were 
purchased from Dharmacon, Inc. (Thermo Scientific). Four sets of IGFBP-3R siRNAs 
were used consisting of a 21-nucleotide sense and antisense strand (Table 2). An 
siCONTROL non-targeting siRNA #1 (Dharmacon) was used as a nonspecific control. A 
mixture of 4 sets of IGFBP-3R siRNAs (total 20nM) were transfected for 6 days into 
M12 prostate cancer cells. Two target sequences corresponding to siRNAs #1 and #3 
were further selected to construct shRNA plasmids using pSUPER RNAi SystemTM 
(OligoEngine) (Table 3). The complementary sequences was annealed together, and 
inserted into the BamHI and HindIII site of pSRN, generating pSRN-IGFBP-3R shRNA 
#1, or pSRN-IGFBP-3R shRNA #3, respectively.   
 
Generation of adenoviral IGFBP-3 and IGFBP-3R 
NotI-XbaI restriction fragments from pcDNA3/wild-type IGFBP-3 cDNA and EcoR1-
Xho1 restriction fragments from CS2-IGFBP-3RF were used to ligate into a NotI-XbaI 
digested pShuttle-CMV and EcoRV digested pShuttle-CMV, respectively. We used SalI-
NotI restriction fragments from pcDNA3.1/LacZ (Invitrogen) were used to ligate into 
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SalI-NotI-digested pShuttle-CMV. Recombination into the pAdEasy viral backbone was 
accomplished in E. coli strain BJ5183 according to the manufacturer’s instructions. The 
recombination was verified and the adenoviral recombinant DNA was transferred to 
DH5. Recombinant pAdEasy plasmids containing CMV-cDNA inserts were purified 
QIAGEN columns (QIAGEN), and transfected QBI-293A cells with 5 μg of PacI-digested 
DNA using the calcium phosphate method (Promega, Sunnyvale, Ca). Cells were 
seeded at 2 x 106 cells per 150-mm culture dish 24 hours prior to transfection. Lysis of 
transfected cells, indicating adenoviral growth, occurred within 4 days. Following 
amplification, lysates containing clonal recombinant adenovirus were prepared from 
150-mm culture dishes and purified by CsCl gradient centrifugation. Recovered virus 
was aliquoted and stored at -20°C in 5mM Tris (pH 8.0) buffer containing 50mM NaCl, 
0.05% bovine serum albumin (BSA), and 25% glycerol. A viral titrate assay was 
performed using a serial dilution infection of QBI-293A cells and counting plaques under 
an overlay of 0.3% agarose, 10% FBS, and 1x DMEM.  The AdEasy system (Quantum 
Biotechnologies, Canada) was used to generate Ad:IGFBP-3 and Ad:IGFBP-3R.   
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Table 2: IGFBP-3R siRNA nucleotide strands 
#1 Sense 5’-GUG AGG AAU GUG UUA GUG UUU-3’ 
  Antisense 5’-ACA CUA ACA CAU UCC UCA CUU-3 
#2 sense 5’- GAC AAC UGG UCC UUA UCA CUU-3’ 
  antisense 5’-GUG AUA AGG ACC AGU UGU CUU-3’ 
#3 sense 5’- GGA ACA AGA CCC GGA CAU UUU-3’ 
  antisense 5’-AAU GUC CGG GUC UUG UUC CUU-3’ 
#4 sense 5’-GGA ACC UGC CUA UAU UUU AUU-3’, 
  antisense 5’-UAA AAU AUA GGC AGG UUC CUU-3’ 
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Table 3: Target sequences of IGFBP-3R siRNAs #1 and #3 for generation of pSRN constructs  
#1 
sense 5’-A TCC CCG TGA GGA ATG TGT TAG TGT TTC AAG 
AGA A CA CTA ACA CAT TCC TCA CTT TTT A-3’, 
(+523 to +544) 
antisense 5’-AGC TTA AAA AGT GAG GAA TGT GTT AGT GTT 
CTC TTG AAA CAC TAA CAC ATT CCT CAC GGG-3’ 
#3 
sense 5’-GAT CCC CGG AAC AAG ACC CGG ACA TTT TCA 
AGA GAA ATG TCC GGG TCT TGT TCC TTT TTA-3’ 
(+300 to +318) 
antisense 5’-AGC TTA AAA AGG AAC AAG ACC CGG ACA TTT 
CTC TTG AAA ATG TCC GGG TCT TGT TCC GGG-3’ 
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IGFBP-3, IGFBP-3GGG, and IGFBP-3R- induced senescence  
Cells were infected with adenovirus at multiplicity of infection (MOI) as indicated 
in the text in 1% media.  After 24 hours infection, the cells were washed once and 
allowed to recover in 10% media for 48 hours. A second adenovirus infection was 
performed in 1% media for 24 hours followed by one time wash. The cells were 
incubated in 10% FBS media for 3 days.  Cells were in culture for 7 days total, at which 
time they were harvested for protein or RNA isolation.  
 
Generation of pSRN- IGFBP-3 and IGFBP-3R shRNA supernatants  
pSRN-IGFBP-3 shRNA viral vector was a generous gift from (Penn State). 
siIGFBP-3R-double stranded RNAs targeting IGFBP-3R were purchased from 
Dharmacon, Inc. IGFBP-3R. To produce retroviral supernatants, a 293T packaging cell 
line was seeded at 35% confluency in 10mm plates and co-transfection with pCL 
ampho, pME VSVg and pSRN plasmid, an empty vector, IGFBP-3 or IGFBP-3R shRNA 
using Fugene 6 reagent (Roche, Inianapolis, In).  Tissue culture medium was collected 
48 hours post transfection, and fresh media was added.  After an additional 48 hours, 
cell medium was pooled, filtered through a 0.45 mm filter and aliquoted.  Viral 
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supernatants were stored at -80oC or supplemented with 4 g/ml polybrene and were 
used immediately for infection of cells combined with target cell media in a 1:1 or 1:2 
ratio.   
 
Senescence associated -galactosidase staining (SA--gal).  
Upon completion of experimental treatment, cells were washed in PBS and fixed 
with 2% formaldehyde/0.2% glutaraldehyde for 10 minutes at room temperature.  Plates 
were stained as described previously (Dimir et al., 1995). Briefly, cells were incubated 
overnight ith  1 mg/ml β-galactosidase substrate (X-gal, Gold BioTechnology, St. Louis, 
MO) prepared fresh in 40 mM citric acid/NaP buffer, pH 6.0, 5 mM potassium 
ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, and 2 mM MgCl at 37C.  
Microscope images were captured at 20x, phase 2 for morphology analysis.  SA--gal 
stained cells were captured at 10x, Phase 1 contrast. A total of 100 cells from 3 random 
fields were counted and scored for positive staining.   
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Cell Viability Assay (MTT Assay) and population doubling rate 
Cell viability was measured by 3-(4,5-dimethylthylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) method (ATCC).  Cells were seeded in triplicate in 
96-well plates, grown to 50% confluency, and treated as indicated. MTT was added to 
the cell culture and incubated for 2 hours at 370C.   Detergent reagent was then added 
and incubated in the dark for 2 hours at room temperature. MTT is reduced by 
metabolically active cells to produce intracellular purple formazan that can be quantified 
by spectrophotometer; the absorbance was measured at 570nm.  To measure cell PD, 
cells were seeded at 40% confluency and cultured in 10% FBS.  Cells were harvested 
by trypsinization at time intervals indicated, stained with trypan blue, and the viable cells 
enumerated by use of a hemocytometer. Triplicate wells of cells were counted 
separately and the results averaged.  
 
Cell Death ELISA Assay 
Apoptotic Cell death was measured using the Cell Death Detection ELISA 
(Roche Applied Sciences) according to the manufacturer’s instructions. Equivalent cell 
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populations were analyzed and absorbance measured at 405nm (reference wavelength, 
49nm).  
 
BrdU cell proliferation assay 
A bromodeoxyuridine (BrdU) cell incorporation assay was performed according 
to the manufacturer’s instructions (Chemicon, Temecula, Ca). Cells were plated 1x104 
per well into 96 well cultures plates. Prior to the end of the incubation time period 
indicated for each experiment, cells were incubated with BrdU for 2 hours. Cells were 
then fixed and denatured, washed in incubated with anti-BrdU for 1 hour at room 
temperature.  Following three washes, the cells were incubated with goat anti-mouse 
IgG peroxidase conjugate for 30 minutes at room temperature, followed by additional 
washings.  TMB peroxidase substrate was then added to cells for 30 minutes at room 
temperature in the dark. Positive cells were visible by blue color, where intensity was 
measured using a spectrophotometer at wavelength 450/540 nm. The amount of BrdU 
incorporation in proliferating cells is proportional to color intensity.  
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DCF Staining 
Dichlorofluorescein diacetate (DCF) is used to detect ROS following senescence 
induction.  After cells were treated and incubated as indicated, cells were incubated for 
30 minutes with medium containing 5mM DCF. Media was then removed and fresh 
media was added. The cells were then immediately visualized for fluorescence. For 
Fluorescence-activated cell sorting (FACS) analysis cells were washed twice with PBS, 
trypsinzed and collected in 1 ml of PBS. Flow cytometric analysis was performed using 
the FC500 combined with CXP software (Beckman Coulter Fullerton, CA).  
 
Immunocytochemistry 
HFL-1 cells were seeded on glass cover slips in 6-well plates and infected with 
adenovirusto induce senescence.  Cover slips were acid cleaned and stored in 70% 
ethanol prior to use. Following senescence induction, cells were rinsed twice with PBS, 
then fixed in 3.7% paraformaldeyde for 10 minutes at RT. After fixation, the cells were 
washed twice with PBS at room temperature and permeabilzed in 0.5% NP-40 in PBS 
for 10 minutes at RT. Following two additional washings, the cells were blocked for 30 
minutes in PBS. The slides were then incubated with yH2AX antibody overnight at 40C,  
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followed by incubation with fluorochrome conjugated secondary antibody for 1 hour at 
RT in the dark.  After washing, DAPI was added to PBS to all the nucluei to be 
visualized. After 2 additional washes for 3 minutes, a drop of VECTASHIELD® mounting 
media (Vector Laboratories, Burlingame, Ca) was added to microscope slide, with 
coverslips being added.   The immuostained cells were visualized by a Nikon Eclipse 
8600 20x magnification, with representative images being captured by Nikon Digital 
Camera DXM1200G, using Nikon ACT-1 image editing program.   
 
Subcellular fraction preparations 
Cell lysates were harvested by washing monolayer cultures in ice-cold PBS. For 
subcellular fraction preparations, plasma membrane, cytosolic and nuclear fractions 
were isolated by homogenizing cells using membrane protein extraction kit (Bio Vision, 
Moutain View, Ca ) and centrifuging successively at 700xg and 100,000X g for 10 and 
60 minutes, respectively. All pellets were solubilized in 50mM HEPES, pH 7.4, 150mM 
NaCl, 2mM MgSO4, 1% Triton X-100. Equal amounts of protein from each fraction were 
analyzed by SDS-PAGE, followed by Western blotting for fractionation specific markers. 
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Statistical analysis 
Analyses of protein or mRNA expression analyzed by western blot or qPCR, 
respectively were evaluated using a student’s t-test with an alpha level set at 0.05.   
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Chapter 3 
Characterization of the role of IGFBP-3 in cellular senescence, replicative and 
prematurely induced senescence  
 
3.1 Introduction and rationale 
The limited proliferative capacity observed in many eukaryotic cell types is often 
interpreted as a manifestation of cellular aging. Irreversible growth arrest at the G1/S 
phase of the cell cycle is due to the overexpression of CDK inhibitors including p21 and 
p16, leading to hypophosphorylation of the Rb protein. Human diploid fibroblasts that 
enter into replicative senescence are characterized by an enlarged cell shape, SA-β-gal 
activity, short telomeres and changes in senescence-associated gene expression. 
Prematurely induced senescence in human diploid fibroblast can display similar 
characteristics, although the mechanism and signaling to enter the senescent state may 
be different.  
GH/IGF axis has long been regarded as one the most conserved pathways in aging and 
longevity.  IGF signaling is known to both promote and inhibit cell growth.  IGFBP-3 is 
the most abundant IGFBP in serum and is responsible for carrying 75% 
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IGF-I and IGF-II in a heterotrimeric ternary complex with an acid-labile subunit.  The 
ternary complex is acted upon by proteases, whereby IGF-1 is released and available or 
interaction with IGF-IR.   A growing body of evidence has demonstrated that IGFBP-3 is 
an important growth-suppressing factor in various cell systems through an IGF-
dependent mechanism.  Although IGFBP-3 is the principal carrier of IGFs in circulation, 
it is also an important component to the GH/IGF axis, playing a role in autocrine and 
paracrine growth control and apoptosis. The IGF-independent actions of IGFBP-3 have 
revealed a large array of signaling proteins with links to cell cycle control and apoptosis.  
The IGFBP-3 promoter contains a p53 binding site that upregulates its transcription 
(BJogie-Brahim et al., 2005).   Debacq-Chainiaux et al, identified IGFBP-3 upregulation 
when screening for senescence-associated genes following repeated exposure to 
sublethal concentrations of tert-butylhydroperoxide (t-BHP) and ethanol [50]. 
Furthermore, several studies have identified IGFBP-3 to be upregulated at both the 
protein and mRNA levels in both replicative and premature senescence (Debacq-
Chainiaux et al, 2008). 
Cells that undergo replicative or prematurely induced senescence are currently 
indistinguishable from one another, suggesting a common downstream signaling 
influenced by multiple extracellular and intracellular signal transduction pathways.  
Identifying pathways by which senescence is replicatively and prematurely, induced and 
maintained, may be critical to understanding the mechanistic causes and consequences 
of organismal aging. 
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3.2 Model of replicative senescence in HFL-1 cells 
Normal human diploid fibroblasts are in incapable of replicating indefinitely 
(Hayflick and Moorehead, 1961).  To investigate the phenotypic and genotypic changes 
associated with cellular senescence, we initially generated an in vitro model of 
replicative senescence using human embryonic lung fibroblasts, HFL-1.  HFL-1 cells 
were originally plated beginning at PD 2 and grown under normal conditions with media 
replaced every two days. Cells were split in 1:4 ratio with each passaging when they 
reached confluency.  At PD24 cells began displaying a senescent morphology but 
continued to proliferate, however by PD50 cells cease to proliferate, but remained viable 
for at least 16 days in culture.  Upon generating various cultures of multiple population 
doublings, cells from PD4, 24 and 50 were seeded at 40% confluency in triplicate.  On 
day 3, 5, 7 and 9 the cells were trypsinized and the cell number counted. PD 4 cells 
became confluent after 3 days and had to be split in a 1:2 ratio on days 3 and 5. A 
cumulative growth curve demonstrating replicative capacity of cells ranging from early to 
late passage is shown in Figure 6A.  This data indicates a progressive decrease in the 
proliferation potential with increased population doublings.  To further confirm our 
replicative senescence model we evaluated the morphological changes and percentage 
of SA-β-gal positive cells (Figure 6B). Compared to early passage cells (PD 4), PD 24 
had approximately 30% positive staining, while PD 50 had 75% positive SA-β-gal 
stained cells.    
Activation of p53 is known to upregulate p21 signaling and both CDK inhibitors, 
p21 and p16, prohibit cell cycle progression from G1 to S phase.  Semi-quantitative  
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Figure 6: Replicative senescence in HFL-1 cells. (A) Cumulative growth curve of 
cells cultured for 9 days with fresh medium every 2 days. Cells were seeded 11 
x103 per well of a 12 well plate in triplicate, n=2. (B) HFL-1cells at PD 4, 24 and 50 
were cultured under normal conditions. When cells reached 95% conflueny 
morphological changes were analyzed by phase contrast microscopy, 20 x (top 
panel) and stained for evaluation of SA-β-gal activity (bottom panel). Percentage 
represents 3 counts of 100 cells, n=3. The continual passing of HFL-1 decreases 
replicative capacity and increase SA-β-gal positive cells and morphology changes 
associated with senescence. PD 24 cells referred to as pre senescent cells and PD 
50 cells are replicatively senescent. 
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real-time RT-PCR was performed with RNA extracted from each PD 4, 24 and 50, with 
β2M being used as a loading reference.  The expression of p16, p21 and p53 in PD24 
increased 2, 3.2 and 7.5 fold, respectively compared to PD 4 cells.  Senescent HFL-1 
cells at PD 50 had an even greater mRNA fold expression of p16, p21 and p53 at 7.2, 
5.8 and 14 fold, respectively (Figure 7A). Western blot analysis of senescence 
associated genes from each PD indicated a significant upregulation of protein 
production correlated to decreases in replicative capacity.   As mentioned earlier, the 
role of p38 MAPK in senescence is emerging as playing a critical role in senescence, 
therefore we examined both the phosphorylated levels, indicative of increased p38 
signaling, and total p38 protein levels (Figure 7B). Indeed, both total and 
phosphorylated p38 MAPK signaling is upregulated in replicatively senescent HFL-1 
cells.  
IGFBP-3 mRNA levels and proteins have been shown to be increased in both 
replicative and prematurely-induced senescent cells (Pascal, et al., 2005). As our 
laboratory has recently published the identification of a novel IGFBP-3R, this is the first 
data identifying upregulation of IGFBP-3R in senescent fibroblasts.  Semi-quantitative 
RT-PCR revealed a significant increase in both IGFBP-3 and IGFBP-3R with increased 
PD (Figure 8A).  As IGFBP-3 is known to be secreted, we incubated cells in serum free 
media for 1, 3 or 5 days before collecting media and harvesting cell lysate. With 
increased cell incubation time, there is an increased accumulation of IGFBP-3 
production. However, an upregulation of IGFBP-3 protein can initially be detected in 
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Figure 7: SA-associated gene expression in HFL-1 cells in replicative 
senescence. Cells were seeded at 70% confluency and 3 days later RNA and 
protein levels evaluated in triplicate , n=3. (A) qPCR evaluation of p21, p16 
and 53 mRNA levels, GAPDH  was used as a loading control. (B) Western blot 
analysis of expression levels of SA-genes and activation of p38 by 
phosphorylation of p38, α-tubulin was used as a loading control. With 
increasing population doubling there is a significant increase in SA-associated 
gene expression on both mRNA protein levels.(*, p ≤ 0.05) 
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Figure 8: IGFBP-3 and IGFBP-3R mRNA and protein expression levels in 
HFL-1 cells at PD 4, 24 and 50. Cells were seeded in triplicate at 75% 
confluency and RNA was isolated 60 hours later, n=3. (A) RT-PCR evaluation 
of IGFBP-3 and IGFBP-3R, and β2M was used as a loading control. (B) Cell 
lysates were harvested for protein analysis after cells were incubated for 1, 3 
or 5 days in serum free media, α-tubulin was used as a loading control. The 
mRNA and protein levels of IGFBP-3 and IGFBP-3R are upregulated with 
increasing PD.  
  
49
presenescent (PD24) fibroblasts (Figure 8B).  In addition, IGFBP-3R production was 
also observed with increased PD. IGFBP-3/R levels are increased way before cells 
undergo senescence, suggesting IGFBP-3/R may be responsible for inducing 
senescence and not entirely for maintenance.  By evaluating proliferative potential, 
morphological changes, SA-β-gal activity and senescence-associated gene expression, 
we established an in vitro model of replicative senescence and from hereon will, 
designate PD4 cells as young, PD24 as presenescent cells and PD 50 as senescent 
cells.   
 
3.2.2 Suppression of endogenous IGFBP-3 
Since IGFBP-3 is upregulated in replicatively senescent cells, we aimed to 
evaluate the effects of suppressing endogenous IGFBP-3 in presenescent, PD24, HFL-
1 cells. To test the efficiency of suppressing endogenous IGFBP-3, we generated viral 
supernatants of either pSRN empty vector or pSRN-IGFBP-3shRNA specifically targeting 
IGFBP-3 mRNA. HFL-1 cells were incubated with viral supernatants of pSRN-EV or 
pSRN-IGFBP-3shRNA for 24 hours, allowed to recover in 10% serum containing media for 
24 hours and incubated for 2 or 4 days in serum-free media before harvesting.  
Endogenous IGFBP-3 protein secretion was significantly suppressed in cells infected 
with IGFBP-3shRNA compared to control and empty vector infected cells, as indicated by 
western blot (Figure 9A).  The effect of suppressing endogenous IGFBP-3 in presecent 
cells was evaluated over a 14 day time point. Cells were seeded at 50% confluency and 
infected for 24 hours. Cells were then grown in 10% media for additional 4 days before  
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Figure 9: Suppression of endogenous IGFBP-3 inhibits senescence. (A) 
Presenescent HFL-1 (PD 24) cells were exposed to pSRN IGFBP-3 siRNA or empty 
vector retrovirus supernatant for 24 hours before fresh media was added for an 
additional 24 hours. (A) Secretion of IGFBP-3 in culture media measured by western 
blot, following 2 days or 4 days in serum free media. (B) SA-β-gal staining following 
suppression of endogenous IGFBP-3, (200x). (C) Protein expression of senescence 
associated genes analyzed by immunoblot following IGFBP-3 suppression.  
Endogenous suppression of IGFBP-3 decreases the number of SA-b-gal positive 
cells and  inhibits the upregulation of senescence associated genes and p38 MAPK 
signaling. (*, p ≤ 0.05) 
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being split in 1:2 ratio.  Since cells were not stably transfected, a second viral infection 
was performed and cells were recovered in 10% serum containing media for 4 more 
days before being passaged in 1:2 ratio. A third and final supernatant infection was 
performed and cells were incubated for an additional three days before cell lysates were 
collected or SA-β-gal activity was measured (Figure 9B). Comparing control, empty 
vector and IGFBP-3 shRNA treated cells at day 14, significant morphological 
differences and decreased SA-β-gal staining.  Control and empty vector had 82% and 
68% SA-β gal staining, respectively, and IGFBP-3 shRNA treated cells had significantly 
less stained cells at 28% (Figure 9B). The increased abundance of senescence 
associated genes p53, p21 and p16 is significantly reduced in cells infected with IGFBP-
3shRNA (Figure 9C). The inhibition of senescence by suppressing endogenous IGFBP-3 
in presenscent cells establishes an essential role of IGFBP-3 in senescence.   
 
3.2.3 IGFBP-3 signaling in Werner Syndrome derived fibroblasts.   
Werner syndrome (WS), a premature aging disorder, is commonly used as a 
model of normal human aging. Recently, it has been reported that WS fibroblasts exhibit 
phenotypes similar to senescent fibroblasts, including increased IGFBP-3 expression 
and phosphorylated p38, suggesting IGFBP-3 may play a key role in senescence 
(Davis, et al., 2005). WS fibroblasts provide a valuable model for allowing in vitro 
senescence mechanisms to be examined in vivo.  IGFBP-3 mRNA is known to be 
upregulated in WS dermal fibroblasts. However, its upregulation compared to age 
matched fibroblasts has not been fully investigated (Murano, et al., 1991).  Initially, we 
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compared the morphology of normal human dermal fibroblasts to WS fibroblasts from 2 
different donors, AG03141 and AG00781, at similar PDs.  It is clearly evident that the 
WS cells exhibit an enlarged, flattened irregular shape compared to the HDF with a 
slender spindle-like shape (Figure 10A).  As p38 MAPK signaling has recently emerged 
as possibly regulating the senescence phenotype of WS cells, we evaluated the 
phosphorylation status of p38 MAPK in addition to IGFBP-3 secreted protein levels 
(Figure 10B).  IGFBP-3 reverses the senescence phenotype similar to early passage 
fibroblasts and surprisingly, there is significant suppression phosphorylated of p38.  
Total p38 protein does not appear to be downregulated, suggesting senescence 
signaling is regulating p38 activity and not protein production in WS cells.  
While it is currently known that SB203580, a p38-specific inhibitor, reverses the 
accelerated senescence phenotype observed in WS fibroblasts (Davis et al., 2005), we 
initiated studies to investigate the effect of IGFBP-3 siRNA on WS cells.  Surprisingly, 
our data shows decreased levels SA-β-gal staining following suppression of 
endogenous IGFBP-3 (Figure 11A). Furthermore, p38 MAPK phosphorylation and 
senescence associated genes were downregulated following IGFBP-3 shRNA treatment 
(Figure 11B). Interestingly, as we have shown IGFBP-3-induced senescence can 
upregulate p38 MAPK activation and endogenous suppression of IGFBP-3 inhibits p38 
activation, we aimed to identify the mechanisms between these two interacting 
pathways. Taken together, suppression of endogenous IGFBP-3 inhibits p38 MAPK 
activity, whereas inhibition of p38 MAPK activation inhibits IGFBP-3 production. Our  
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Figure 10: Expression of IGFBP-3 levels in Werner Syndrome cells and normal 
Human dermal fibroblast (HDF) at same population doubling (PD8). HDF and WS 
cells derived from two different donors, AG03141 and AG00718 were seeded at 80% 
confluency.  (A) analyzed for morphological changes by phase contrast microscopy, 20 x 
(top panel) and (B) Cell lysates and culture media were harvested and measured by 
western blot following incubation for 3 days in serum free media. Densitometric analyses 
of phosphorylated p38, total p38 and IGFBP-3, α-tubulin was used as a loading control 
to indicate protein changes, n=2. (*,p ≤ 0.05). WS fibroblasts appear to resemble 
rpelicative senescence cells compared to normal HDF at similar PD.  WS cells also have 
upregualated IGFBP-3  and p38 MAPK protein expression levels compared to HDFs. 
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Figure 11: Suppression of endogenous IGFBP-3 in WS fibroblast reverses 
senescence phenotype. AG00781 WS cells were infected with IGFBP-3 shRNA or 
empty vector retrovirus supernatant for 12 hours allowed to recover for 48 hours in fresh 
10% media. Protocol was repeated 3 times for a total of 8 days in culture. (A) SA-β-gal 
staining cells was performed 60 hours after final infection, 100 cells per count in 3 
counts, n=2 , magnification at 20x). (B) Serum free media replaced serum-containing 
media following final infection and cell media and lysates were collected 48 hours. 
Secretion of IGFBP-3 and p38 MAPK expression were analyzed by western blot, α-
tubulin was used as loading control. IGFBP-3 shRNA decrease the number of SA-β-gal 
positive cells and decreases p38 MAPK phosphoyrlation. Densitometric analysis 
compares control versus treated cells for statistical significance (*, p ≤ 0.05).   
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findings strongly suggest IGFBP-3/IGFBP-3R axis may be a major signaling pathway in 
cellular aging.  
 
3.2.4 IGFBP-3 overexpression induces premature senescence.  
IGFBP-3 upregulation in senescence appears to be critical, as its endogenous 
suppression can inhibit and reverse senescence.  To further evaluate an essential role 
of IGFBP-3 in senescence, we investigated the effects of overexpressing IGFBP-3 and 
its novel receptor in early passage HFL-1 cells. Moreover, we aimed to investigate the 
effects of IGFBP-3 independent of IGF. Therefore, we utilized mutated IGFBP-3, 
IGFBP-3GGG, which has no binding affinity for IGF. We have published reports regarding 
the proapoptotic effect of IGFBP-3 and IGFBP-3GGG in various cancer cell lines. 
However, the present study is novel as it investigates the effects of IGFBP-3 
upregulation in normal non-immortalized cells. Early passage, PD4, fibroblasts were 
infected with adenovirus expressing IGFBP-3, IGFBP-3GGG, IGFBP-3R or empty vector. 
After two infections and a total of 7 days in culture, cells were analyzed for viability by 
MTT assay (Figure 12A) and apoptosis by Cell Death ELISA (Figure 12B).   MTT 
analysis indicated IGFBP-3, IGFBP-3GGG nor IGFBP-3R remained viable, in contrast to 
what has previously been observed in cancer cells. Furthermore, adenovirus treatment 
did not induce apoptosis, compared to positive control etoposide treatment. At MOI 250, 
cells death occurred indicated cell toxicity of virus rather than IGFBP-3 or IGFBP-3R 
induced apoptosis. Adenovirus treatment at MOI 100 did not significantly increase Cell 
Death ELISA absorbance measurements. This suggests IGFBP-3 can activate  
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Figure 12: Overexpression of IGFBP-3 in HFL-1 cells does not induce 
apoptosis. Early passage cells were adenovirus infected with EV, IGFBP-3, 
IGFBP-3GGG or IGFBP-3R at MOI 100 on day 0 and day 3 of a 7 day incubation. (A) 
Cell viability was measured by MTT assay in triplicate, n=3. (B) To assess 
apoptosis induction after final treatment, equal cell numbers were analyzed by Cell 
Death ELISA in triplicate, n=3. As a positive control cells were treated 24 hours with 
500μM etoposide. As EV (250) had significantly increased absorbance compared to 
control, adenovirus IGFPB-3, IGFBP-3GGG and IGFBP-3R treated samples were 
analyzed for statistical significance compared to EV treated samples same similar 
MOI. (*, p ≤0.05) Overepxression of IGFBP-3 and IGFBP-3R does not induce 
apoptosis.    
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divergent signaling pathways in normal versus cancer cells. If IGFBP-3 did not promote 
cell death and cells remained viable for 7 days, we proceeded to determine the effects 
on proliferation capacity and any possible hallmark characteristics of senescence. HFL-
1 PD4 cells were seeded at 40% confluency in triplicate and infected twice with 
adenovirus. On days 0, 3, 5, and 7 cell numbers were calculated and a cumulative 
growth curve was generated (Figure 13A). Non-treated and empty vector treated cells 
both exhibited normal proliferation capability, as cell numbers doubled every two days. 
However, IGFBP-3, IGFBP-3 GGG, IGFBP-3R adenovirus infection caused a significant 
inhibition of cell proliferation beginning on day 3.  Although there appears to be a 
substantial inhibition in replication, not all cells undergo growth arrest as the growth 
curve does not plateau. Another experimental method used to confirm inhibition of cell 
replication is BrdU incorporation. As cells replicate, BrdU becomes incorporated into 
DNA synthesis and therefore increased BrdU staining is indicative of DNA replication.  
IGFBP-3 and IGFBP-3R infected cells showed significantly decreased BrdU 
incorporation compared to empty vector virus and control cells, confirming a cell growth 
arrest (Figure 13B).  IGFBP-3 does not induce apoptosis in normal cells contradictory to 
cancer cell signaling.  However, IGFBP-3 does induce cell growth inhibition in normal 
cells as demonstrated by lack of BrdU incorporation and decrease cell replication. 
Adenovirus treated cells were fixed and stained for SA-β-gal analysis and 
morphological changes were observed (Figure 14, bottom panel, top panel, 
respectively). As control and EV treated PD4 cells displayed slender spindle-like 
morphology, IGFBP-3, IGFBP-3 GGG, IGFBP-R displayed a large flat, irregular shape  
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Figure 13: Overexpression of IGFBP-3 in HFL-1 cells prohibits cell
proliferation and inhibits DNA synthesis. HFL-1 (PD5) cells were seeded in 2.2
x105 per 12 well plate in triplicate and infected twice with adenovirus empty vector,
IGFBP-33, IGFBP-3GGG or IGFBP-3R at MOI 100 on day 0 and day 3 of a 7 day
incubation. (A) On days 3,5 and 7 cells were trypsinzed, stained with trypan blue
and counted. Cumulative growth curve was generated, each time point represents
average of triplicate samples, n=3. (B) On day 5 cells were trypsinzed and seeded
in triplicate in 96 well plate for determination of DNA synthesis by BrdU
incorporation. (*,p ≤0.05) IGFBP-3 and IGFBP-3R overexpression inhibits
replicative capacity and inhibits BrdU incorporation.
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Figure 14: Overexpression of IGFBP-3 induces senescence. Early
passage cells infected 2x with adenovirus empty vector, IGFBP-3 or IGFBP-
3GGG at MOI 100 on day 0 and day 3 of a 7 day incubation. (A), Morphology
observations were photographed at 20x phase contrast magnification.  SA-β-
gal staining was performed, and percentages represent average of 100 cells
from 3 fields, n=2. Overexpression of IGFBP-3 and IGFBP-3R increases SA-
β-gal positive cells indicative of senescence induction. 
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and significantly increased SA-β-gal activity, 50% and 62% and 42% respectively 
compared to 2% control or 3% empty vector adenovirus (Figure 14). Here we 
demonstrated IGFBP-3, IGFBP-3 GGG or IGFBP-R can cause early passage cells to 
exhibit a similar phenotype observed in replicative senescence and significantly 
increased SA-β-gal positive cells (Table 1).  
Overexpressing IGFBP-3, IGFBP-3 GGG, IGFBP-R resulted in the significant 
upregulation of senescent-associated genes p53, p21, p16 and phosphorylated p38 
(Figure 15 and Table 1).  Many stimuli that can trigger replicative or premature 
senescence signaling are known to upregulate SA gene expression. However, we have 
clearly demonstrated IGFBP-3 may possibly be an upstream target of these cell cycle 
regulator genes.  These data support our hypothesis that IGFBP-3 upregulation does 
not induce apoptosis or alter cell viability, as previously seen in cancer cells, but more 
importantly induces growth arrest defined as cellular senescence. 
 
3.2.5 IGFBP-3-induced senescence independent of telomerase.  
Telomere shortening is universally accepted as a major regulator of replicative 
senescence, yet no information currently indicates a role of IGFBP-3 in telomere 
shortening or telomere end fusion.  Numerous studies have demonstrated, senescence 
induction is not exclusively dependent on telomere length as despite the presence of 
telomerase, cells can still enter a senescence state (Allsopp, et al., 1992 and 1995 and 
Itahana et al., 2004).  
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Figure 15: Regulation of expression of SA-genes following IGFBP-3-induced
senescence. Early passage cells infected twice with adenovirus empty vector,
IGFBP-3 or IGFBP-3GGG at MOI 100 on day 0 and day 3 of a 7 day incubation.
(A) Cells lysates were collected and analyzed by western blot, α-tubulin was
used as a loading control. Senescence associated genes were measured by
densiometric analysis. Statistical analysis compared control cells versus
adenovirus infected cells (*, p ≤ 0.05). Overexpression of IGFBP-3 and
IGFBP-3R increases SA gene expression indicative of senescence induction. 
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% SA- -stain 
positive cells p53 p value p16 p value
Control 2.1 ± 0.2 % 1 1
Ad: EV (100) 2.82 ± 0.17 % 1.01 ± 0.037 0.442 1.02 ± 0.120 0.807 1.
Ad: IGFBP-3 (100) 50.03 ±  3.01 % 2.82 ± 0.144 0.002 2.968 ± 0.147 0.002 3.22
Ad:IGFBP-3GGG (100) 62.4 ± 1.54  % 2.94 ± 0.176 0.002 2.732 ±.102 0.001 2.
Ad:IGFBP-3R (100) 41.43 ± 0.85 % 2.89 ± .061 0.003 2.768 ± 0.135 0.001 2.92
Table 1:Overexpression of IGFBP-3 and IGFBP-3R significantly upregulates SA- -gal staining and S
p21 p value
1
09 ± 0.126 0.338
1 ± 0.090 0.001
70 ± 0.314 0.012
0 ± 0.090 0.011
A gene expression.
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To investigate if telomere end fusions were generated following IGFBP-3-induced 
senescence in HFL-1 cells, we initially attempted to prepare metaphase chromosomes 
from IGFBP-3- induced senescent cells. Unfortunately the dilemma with this assay is 
IGFBP-3 treated cells cease proliferating and do not enter mitosis, preventing one from 
harvesting metaphase chromosomes.  As a result we could not proceed with this assay.      
We then aimed to examine if IGFBP-3 induced senescence was dependent on 
telomerase activity.  Using BJ and BJ/hTERT, which are immortalized and have stably 
transfected telomerase, respectively, we analyzed the results of overexpressing IGFBP-
3. BJ fibroblasts undergo replicative senescence at approximately PD65 therefore; we 
used PD27 in our experimentation.  BJ (PD27) cells were infected with adenovirus 2x 
and cultured for a total of 7 days before analyzing for senescence induction. The cells 
were fixed and stained for SA-β-gal analysis and morphological observations (Figure 
16, bottom panel, top panel, respectively). The control and EV treated BJ cells 
displayed normal fibroblast morphology, while IGFBP-3, IGFBP-3 GGG, IGFBP-R 
displayed a large flat, irregular shape and significantly increased SA-β-gal activity, 62% 
56% and 72% respectively compared to 26% control or 28% empty vector adenovirus 
(Figure 16). Here we demonstrated IGFBP-3, IGFBP-3 GGG or IGFBP-R can causes BJ 
(PD24) cells to exhibit a similar phenotype observed in replicatively senescent cells. 
Next we examined if telomerase activity would inhibit IGFBP-3-induced senescence. 
Surprisingly, BJ/hTERT (PD53) entered into a senescence phenotype with significant 
morphology changes and increased SA-β-gal activity following adenovirus infection 
(Figure 17). Unexpectedly, it appeared BJ/hTERT had more SA-β-gal stained cells than  
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Figure 16: Overexpression of IGFBP-3 in human foreskin fibroblasts (BJ) at PD
27. BJ cells were seeded at 30% confluency and infected with adenovirus in 1%
serum containing media for 24 hours. Cells were incubated for 48 hours in 10%
media followed by a second adenovirus infection for 24 hours. Serum free media was
added and cells were incubated for an additional 60 hours. Cell were fixed for
analysis of morphological observations (top panel) or stained for SA-β-gal positive
cells (bottom panel). Cells were photographed at 20x magnification phase contrast
microscopy. Percentages represent average of 3 100 cells counts, n=2. (*,p ≤0.05)
Overexpression of IGFBP-3/R can induce senescence as detected by increased SA-
β-gal positive cells.  
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Figure 17: Overexpression of IGFBP-3 hTERT immortalized human foreskin 
fibroblasts (BJ/hTERT) at PD 53. Cells were seeded at 30% confluency and 
infected with adenovirus in 1% serum containing media for 24 hours. Cells were 
incubated for 48 hours in 10% media followed by a second adenovirus infection for 
24 hours. Serum free media was added and cells were incubated for an additional 60 
hours. Cell were fixed for analysis of morphological observations (top panel) or 
stained for SA-β-gal positive cells (bottom panel). Cells were photographed at 20x 
magnification phase contrast microscopy. Percentages represent average of 3 100 
cells counts, n=2. (*,p ≤0.05) Overexpression of IGFBP-3/R can induce senescence 
despite expression of telomerase, as detected by increases SA-β-gal positive cells.  
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BJ cells at PD27.  This finding suggests differential regulation of IGFBP-3 
signaling based on cell type.  From a gene expression perspective, overexpressing 
IGFBP-3, IGFBP-3 GGG, IGFBP-R resulted in the significant upregulation of senescent 
associated genes p53, p21, and p16. Surprisingly, we could not detect phosphorylated 
p38 in both BJ and BJ/hTERT fibroblasts although there does not appear to be a 
change in total p38 protein (Figure 18A, B, respectively).  This may suggest IGFBP-3 
induced senescence in BJ fibroblasts is not entirely dependent on p38 MAPK or the 
time point to evaluate p38 activity needs to be investigated.  Another speculation is p38 
levels are difficult to detect in these particular cells. 
In conclusion, we have identified upregulation of IGFBP-3 and IGFBP-3R in 
replicatively senescent HFL-1 cells. We further demonstrated IGFPB-3, IGFBP-3GGG 
and IGFBP-3R can induce premature senescence, as indicated by senescent 
morphology changes, increased SA-β-gal positive cells, and increased expression of 
senescence-associated genes. Moreoever, we demonstrate IGFBP-3/IGFPB-3R can 
signal p38 MAPK pathway activation.  IGFBP-3/IGFBP-3R can also induce senescence 
independent of telomerase activity.   The suppression of endogenous IGFBP-3 inhibits 
senescence induction in HFL-1 cells and reverses the senescence phenotype in WS 
fibroblasts.  For the first time, we have demonstrated IGFBP-3 regulation on p38 MAPK 
signaling, as IGFBP-3 upregulation increases p38 activity and suppression of IGFBP-3 
inhibits its upregulation.  How IGFBP-3 is upregulated in senescent cells and how 
IGFBP-3 interacts with p38 signaling pathway remains to be elucidated.  
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Figure 18: Expression of senescence associated genes in IGFBP-3-
induced senescence BJ (PD27) cells and BJ/hTERT (PD53) immortalized.
BJ and BJ/hTERT cells were seeded at 30% confluency and adenovirus
infected in 1% serum containing media for 24 hours. Cells were incubated for
48 hours in 10% media followed by a second adenovrius infection for 24
hours. Serum free media was added and cells were incubated for an
additional 60 hours. Cell lysates were harvested and analyzed for SA gene
expression by western blot, n=2. (A) BJ cells (B) BJ/hTERT cells Both BJ and
hTERT expression BJ cells have upregulated expression of SA-genes
following senescence induction by overexpression of IGFBP-3 and IGFBP-3R.
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Chapter 4 
Potential mechanisms for IGFBP-3-induced senescence and IGFBP-3 
upregulation 
4.1 Introduction and Rationale 
Senescence is a complex cell process, therefore it is unlikely to result from 
activation of single pathway, but rather from collaborative changes in multiple pathways, 
that can be triggered by diverse stimuli. Although the characteristics of senescence, 
such as growth arrest, morphological changes, and changes in gene expression are 
indistinguishable, the mechanisms that induce these characteristics have not been 
entirely elucidated.   
In this study, we demonstrated IGFBB-3 and IGFBP-3R expression is 
upregulated in replicative senescence and furthermore, overexpression of IGFBP-3 
and/or IGFBP-3R can induce premature senescence in normal diploid fibroblasts.  
Although several other studies suggest involvement of IGFBP-3 in senescence, the 
mechanism(s) by which IGFBP-3 expression is regulated senescence or what 
pathway(s) IGFBP-3 can signal to induce senescence have yet to be identified. 
Interestingly, when we induced senescence by overexpressing IGFBP-3 or IGFBP-3R, 
in addition to upregulated senescence associated genes, we identified p38 MAPK 
activation in our cell system p38 has been described as causative and a conserved 
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pathway in senescence signaling, as it’s activation is signaled by diverse stimuli, 
including telomere shortening, oncogene overexpression and oxidative-stress. Although 
the upstream stimuli induced activation of different pathways, p38 appears to be a 
conserved downstream target.  However, p38 signaling can induce multiple downstream 
effectors depending on its upstream inducer in order to elicit a range cell process such 
as cell growth inhibition, apoptosis or senescence (Iwasa, et al., 2003).  The conserved 
characteristic of p38 signaling is further confirmed p38 activation appears to be a critical 
regulator of senescence in both mouse and human fibroblasts, despite the fact that both 
these cells have significantly different contributions of p53 and Rb signaling (Iwasa, et 
al., 2003).  Characterization p38 signaling, as being conserved, induced by multiple 
senescence stimuli and its ability to signaling various downstream targets, suggest a 
possible relationship with IGFBP-3/IGFBP-3R signaling as IGFBP-3/IGFBP-3R to have 
similar biological functions.  IGFBP-3 is known to be upregulated by multiple 
senescence stimuli; however, the downstream effects have yet to be unmasked.     
As suggested in the free radical theory of aging, several studies have confirmed 
the significance of oxidative stress and/or the decreased antioxidant defense in 
regulating biological aging (Harman, 2006).   ROS, such as hydrogen peroxide and 
hydroxyl radicals have various effects vital to biological processes, including cell growth, 
apoptosis and senescence (Finkkel, 2003).  The ability of cells to maintain a balance is 
crucial for cell viability, as am imbalance between ROS and antioxidants can lead to 
detrimental effects, such as aging.  However, cells aim to maintain a balance between 
oxidative stress and anti-oxidant defenses (Finkkel, 2003).   Several studies have 
shown that oxidative-stress-induced senescence can increase IGFBP-3 production, but 
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it is not entirely known whether IGFBP-3 is an upstream activator of ROS or a 
downstream effecter of ROS signaling.  (Debacq-Chainiaux, et al., 2008).    
IGFBP-3 has long been studied as a primary regulator of IGF signaling; however 
IGFBP-3’s IGF-independent effects are known signal growth cell inhibition and 
apoptosis in various cell lines. Our laboratory recently published the identification of 
novel IGFBP-3R that regulates IGFBP-3-induced caspase-8 dependent apoptosis in 
cancer cells (Ingermann, et al., 2010).  The data from this publication indicates IGFBP-3 
signaling is chiefly mediated through IGFBP-3R, as IGFBP-3R suppression can inhibit 
the apoptotic effects of IGFBP-3.        
By exploiting the significance of ROS signaling and p38 signaling, we aimed to 
determine how the IGFBP-3/IGFBP-3R axis may be interacting between these two 
senescence regulating processes. In our initial studies, we demonstrate a significant 
role of IGFBP-3/IGFBP-3R axis in senescence both replicative and prematurely 
induced.  In order to better understand this pathway, we will need to examine how 
IGFBP-3 is being upregulated and/or suppressed in senescent cells and young normal 
cells, respectively.  Taking into account the significance of ROS in organismal aging and 
senescence signaling and the identification of IGFBP-3/IGFBP-3R regulation of p38, we 
propose a possible relationship between ROS, p38 and IGFBP-3/IGFBP-3R signaling.  
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4.2 Results 
4.2.1 Upregulation of ROS production in IGFBP-3 induced senescence  
In Chapter 3, we clearly demonstrate IGFBP-3/IGFBP-3R can induce 
senescence, and more over cause p38 MAPK activation.  Next we aimed to investigate 
if IGFBP-3-induced senescence could cause an increase in intracellular ROS 
production.  To measure ROS production we quantified levels of 2'7'-dichlorofluorescein 
diacetate (DCF-diacetate). DCF-A can readily cross the cell membrane and become 
intracellular hydrolyzed by esterases to non-fluorescent DCF, which is then rapidly 
oxidized by ROS to produce the fluorescent DCF product that can be quantified by flow 
cytometry.  Fluorescence emitted by the oxidation products of DCF allows for the 
estimation of ROS levels in vitro.  IGFBP-3 was induced as previously described, and 
following senescence induction cells were treated with DCF for 30 minutes and 
analyzed by FACS.  Control and empty vector treated cells showed 15% and 16% 
fluorescence, respectively (Figure 19). IGFBP-3, IGFBP-3GGG and IGFBP-3R 
adenovirus treated cells showed significantly higher percentages of fluorescence at 
68%, 51% and 33%, respectively. Treatment of cells with H202 for 2 hours prior to DCF 
treatment was used as a positive control, showing 73% fluorescence (Figure 19).  We 
have shown for the first time that IGFBP-3/IGFBP-3R-induced senescence can 
significantly increase ROS production.   
Under normal cellular regulation, ROS accumulation can be combated by 
antioxidant enzymes used to detoxify free radical species, such as catalase and 
MnSOD. Glutathione (GSH) is an additional antioxidant that prevents ROS damage by  
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Figure 19: IGFBP-3-induced senescence in HFL-1 cells increases 
intracellular ROS production. HFL-1 (PD7) cells were adenovirus infected 
twice with EV, IGFBP-3, IGFBP-3GGG or IGFBP-3R at MOI 100 for a total of 7 
days in culture. (A) Intracellular ROS levels were measured by FACS analysis 
after staining with the fluorescent probe DCF. A 2 hour treatment with 300 M 
H202 was used as positive control. Percentage represents average fluorescence 
of duplicate samples, n=3. Statistical significance was measured between 
control and treated cells. (*, p≤0.05) IGFBP-3/IGFBP-3R-induced senescence 
causes an increased accumulation of ROS production detected by FACS.  
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scavenging free radicals.   GSH is commonly used in vitro to study the antioxidant tide 
that can donate an electron to unstable molecules, such as ROS.   
If IGFBP-3 and IGFBP-3R increased ROS production following senescence 
induction, we examined if GSH treatment could prevent both ROS accumulation and 
IGFBP-3 induced senescence. Two hours prior to adenovirus treatment and on day 6 of 
7 day treatment, cells were incubated with 10mM GSH.  FACS analysis indicated that 
GSH could inhibit ROS production.  As seen in Figure 20, cells infected with adenovirus 
IGFBP-3 or IGFBP-3GGG in the presence of GSH had a shift towards the left at similar 
levels to control and empty vector infected. The shift represents a decreased 
accumulation of ROS compared to cells that did not received GSH, but underwent 
senescence following adenovirus treatment.  To evaluate senescence inhibition cells 
were stained for activity. In the presence of GSH, IGFBP-3 or IGFBP-3GGG infected cells 
showed decreased number of SA--gal positive cells, from 80% to 48% and 75% to 
46%, respectively (Figure 21, bottom panel). Moreover, senescence morphological 
changes were not exhibited with ROS inhibition by GSH treatment (Figure 21, top 
panel).  This data indicates GSH inhibits ROS accumulation and prevents IGFBP-3-
induced senescence.      
As we have demonstrated IGFBP-3-induced senescence caused upregulation of 
senescence-associated genes, we investigated if this upregulated expression would be 
inhibited by GSH treatment.   GSH treatment significantly inhibited IGFBP-3-induced 
upregulation of p53, p21 and p16 compared to cells without GSH treatment (Figure 
22A-C).  We speculated ROS upregulation was inducing p38 activation; therefore we 
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Figure 20: ROS accumulation in IGFBP-3-induced senescence is 
inhibited by treatment with 10 mM GSH, analyzed by FACS. HFL-1 (PD7) 
cells were adenovirus infected twice with EV, IGFBP-3 , IGFBP-3GGG or at 
MOI 100 for a total of 7 days in culture.2 hours prior to each adenovirus 
infection and on day 6, cells were incubated with 10 mM GSH.  (A) 
Intracellular ROS levels were measured by FACS analysis after staining with 
the fluorescent probe DCF. A 2 hour treatment with 300 M H202 was used as 
positive control. Graph represents n=3, of duplicate samples. ROS 
accumulation following IGFBP-3-induced senescence is inhibited by GSH 
treatment. 
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Figure 21: Inhibition of ROS accumulation, by treatment with 10 mM
GSH, in IGFBP-3-induced senescence. HFL-1 (PD7) cells were 
adenovirus infected twice with EV, IGFBP-3, IGFBP-3GGG all at MOI 100 for 
a total of 7 days in culture. 2 hours prior to each adenovirus infection and on 
day 6, cells were incubated with 10 mM GSH. Cell were fixed for analysis of 
morphological observations (top panel) or stained for SA--gal positive cells 
(bottom panel). Cells were photographed at 20x magnification phase 
contrast microscopy. Percentages represent average of 3 100 cells counts, 
n=2. (p≤0.05) #,  represent statistical significance compared to empty vector 
infected cells. *, represents significant suppression compared to adenovirus 
infection without GSH treatment. GSH ihibits IGFBP-3-induced senescence, 
as demonstrated by decreased SA--gal positive cells. 
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Figure 22: Senescence associated protein expression with 10 mM 
GSH, in IGFBP-3-induced senescence. HFL-1 (PD7) cells were 
adenovirus infected twice with EV, IGFBP-3 , IGFBP-3GGG or IGFBP-3R at 
MOI 100 for a total of 7 days in culture.2 hours prior to each adenovirus 
infection and on day 6, cells were incubated with 10 mM GSH. Cell lysates 
were harvested and analyzed for SA gene expression (A) p53,and (B) 
p21by western blot. Densitometric analyses of triplicate samples were 
measure and graphed. -tubulin was used as loading control. (p ≤0.05) #, 
represent statistical significance compared to control cells. *, represents 
significant suppression compared to adenovirus infection without GSH 
treatment.  SA-gene are upregulated in IGFBP-3/R-induced senescence, 
however GSH treat can prevent this upreulation and inhibit senescence.s 
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Figure 22: Senescence associated protein expression with 10 mM GSH, in 
IGFBP-3-induced senescence. HFL-1 (PD7) cells were adenovirus infected twice 
with EV, IGFBP-3, IGFBP-3GGG or IGFBP-3R at MOI 100 for a total of 7 days in 
culture.2 hours prior to each adenovirus infection and on day 6, cells were incubated 
with 10 mM GSH. Cell lysates were harvested and analyzed for SA gene expression 
(C) p16 and (D) IGFBP-3 by western blot. Densitometric analyses of triplicate 
samples were measure and graphed. -tubulin was used as loading control. (p≤0.05) 
#, represents statistical significance compared to control cells. *, represents 
significant suppression compared to adenovirus infection without GSH treatment.  
SA-gene expression is upregulated in IGFBP-3/R-induced senescence, however 
GSH treat can prevent this upreulation and inhibit senescence. 
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examined both total and phosphorylated p38 in the presence of GSH (Figure 23).  
Densitometry measurement revealed a significant increase in phosphorylated p38, as 
the levels of total p38 remained unchanged (Figure 23).  These data suggest IGFBP-
3/IGFBP-3R signaling pathway can induce ROS accumulation and downstream p38 
signaling. This signaling sequence, IGFBP-3ROSp38senescence is confirmed as 
inhibition of ROS accumulation using GSH treatment inhibits p38 signaling and 
subsequently, senescence.   
To evaluate the significance of p38 signaling in IGFBP-3-induced senescence, 
we examined if p38 inhibition could inhibit IGFBP-3–induced senescence. Similar to 
treatment with GSH, the p38 inhibitor SB203580 was used two hours prior to 
adenovirus infection and a third treatment on day 6.  Cell lysates were analyzed by 
western blot.  We observed a significant decrease in the SA genes, (Figure 24). In 
Figure 25, we show a suppression of phosphorylated p38, but not total p38 protein, 
following IGFBP-3 induced in the presence of SB203580.  Taken together, we 
demonstrated IGFBP-3/IGFBP-3R-induced senescence was inhibited by p38 inhibition, 
suggesting p38 signaling is a crucial downstream target of in IGFBP-3 signaling 
pathway.  
 
4.2.2 miRNA involved in IGFBP-3 regulation 
The regulation of gene expression in response to senescence stimuli are 
numerous and complex, from transcription and translational levels to protein stability.    
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Figure 23: p38 MAPK signaling with 10 mM GSH during IGFBP-3-induced 
senescence. HFL-1 (PD7) cells were adenovirus infected twice with EV, IGFBP-
3, IGFBP-3GGG or IGFBP-3R at MOI 100 for a total of 7 days in culture.2 hours 
prior to each adenovirus infection and on day 6, cells were incubated with 10 
mM GSH. Cell lysates were harvested and analyzed for SA gene expression 
p38 MAPK signaling by western blot.  Densitometric analysis of triplicate 
samples were measured and graphed. -tubulin was used as loading control. (p 
≤0.05) #, represents significance compared to control cells, and *, represents 
statistical analysis between adenovirus treated in absence or presence of GSH. 
#, represent statistical significance compared to control cells. *, represents 
significant suppression compared to adenovirus infection without GSH 
treatment.  p38 MAPK signaling is upregulated in IGFBP-3/R-induced 
senescence, however GSH treat can prevent this upreulation and inhibit 
senescence. 
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Figure 24: Senescence associated protein expression with 10 M 
pSB203580, in IGFBP-3-induced senescence. HFL-1 (PD7) cells were 
adenovirus infected twice with EV, IGFBP-3, IGFBP-3GGG or IGFBP-3R at 
MOI 100 for a total of 7 days in culture. 2 hours prior to each adenovirus 
infection and on day 6, cells were incubated with 10 mM GSH. Cell lysates 
were harvested and analyzed for SA gene expression (A) p53, (B) p21, 
and (C) p16. Densitometric analyses of triplicate samples were measure 
and graphed. -tubulin was used as loading control. (p ≤0.05) #, represent 
statistical significance compared to control cells. *, represents significant 
suppression compared to adenovirus infection without SB203580 
treatment.  SA-gene expression is upregulated in IGFBP-3/R-induced 
senescence; however inhibition of p38, by SB203580, can prevent this 
upreulation and inhibit senescence.  
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Figure 25: p38 MAPK signaling after expression with 10 mM pSB203580, in 
IGFBP-3-induced senescence. HFL-1 (PD7) cells were adenovirus infected 
twice with EV, IGFBP-3 , IGFBP-3GGG or IGFBP-3R at MOI 100 for a total of 7 
days in culture.2 hours prior to each adenovirus infection and on day 6, cells were 
incubated with 10 mM GSH. Cell lysates were harvested and analyzed for SA 
gene expression p38 MAPK signaling by western blot.  Densitometric analyses of 
triplicate samples were measure and graphed. -tubulin was used as loading 
control. (p ≤0.05) #,  represent statistical significance compared to control cells. *, 
represents significant suppression compared to adenovirus infection without GSH 
treatment.  p38 MAPK signaling is upregulated in IGFBP-3/R-induced 
senescence, however inhibition of p38, by SB203580, can prevent this upreulation 
and inhibit senescence. 
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Although it has been almost 20 years since microRNAs (miRNA) have been discovered, 
it has only been in the last 10 years that miRNAs were recognized to have distinct post-
transcriptional regulatory functions.  miRNas are small, noncoding RNAs that regulate 
gene expression by targeting mRNAs for translational repression (Bartel, 2009).  The 
recent surge in biological functional studies of miRNAs presents an additional 
mechanism by which genes with diverse function on multiple pathways may be 
regulated.  miRNAs regulate gene expression at the post-trasncriptional level affecting 
translational and stability of miRNAs (Bartel, 2009).  RNA piolymerase II transcribes 
miRNA and the primary transcript is cleaved by Drosha ribunuclease III enzyme to 
produce an approximately 70-nt stem loop (Bartel, 2004).  Subsequently, the stem loop 
is cleaved by cytoplasmic Dicer to generate a noncoding mature miRNA product, 
approximately 20-24 nt long (Bartel, 2009).  miRNAs are incorporated into RNAs to 
induce silencing complex (RISC) which target the 3’ UTR of target mRNAs through base 
pairing with the miRNA (Bartel, 2004). Although there are few exceptions, most miRNAs 
inhibit translational or destabilization of the target mRNA.    
Lafferty-Whyte et al., (2009) recently identified senescence-associated miRNA 
targets that suggested a common process that regulates different senescence 
induction. After analysis of miRNAs upregulated following various senescence inducing 
pathways, miR-499 and miR34a were the two common regulators of all senescence 
stimuli (Lefferty-Whyte, et al., 2009).  
Using TargetScanS and PicTar software, sequence alignment predictions 
identified four highly and three poorly conserved miRNAs targets of the 3’-UTR region of 
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IGFBP-3 (Figure 26).  p53 is known to be a primary regulator of cellular senescence, yet 
the mRNA expression pattern differs between replicative senescence and premature 
senescence (Shelton, et al., 1999 and Komarova, et al., 1998). miR-34a is commonly 
referred to as tumor suppressor and known to be regulated by p53 ( Kumamoto, et al., 
2008). Studies have shown that miR-34s (mir-34a, mir-34b, and mir-34c) are 
downstream effectors of p53-dependent senescent and apoptotic pathways (He et al., 
2007 and Chang, et al., 2007). To date little data has been published regarding the 
biological function of miR-381, although there are over 300 predicated target genes.  
Currently, there are over 600 genes with predicated miR-19a target sequences.  miR-
19a is a member of miR-17–92 cluster of seven miRs (miR-17–5p, miR-17–3p, miR-18, 
miR-19a, miR-20, miR-19b-1, and miR-92-1) (Quin, et al., 2009). 
 After sequence analysis, we selected 3 of the highly conserved predicated 
miRNA targets, miR-19a, miR-381 and miR-34 and examined the expression levels of 
each miRNA in HFL-1 cells at PD6 and PD48 (Figure 27).  Although previous reports 
have shown increased miR34a expression in replicative and prematurely-induced 
senescent cells, we found no significant upregulation in our cell system. In addition, 
miR-381 did not appear to be differentially expressed between cell PD.  We did however 
note an 80% significant decrease in miR-19a expression correlated to increased 
thatIGFBP-3 mRNA expression in late passage HFL-1 cells (Figure 27).   
As miR19a was significantly downregulated in correlation to increased IGFBP-3 
levels, we aimed to evaluate the effects of upregulated miR-19a in late passage 
fibroblast. HFL-1 (PD45) cells were transfected with pre-miR19a or pre-miR-FAM  
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Figure 26: The predicted sequence alignment of miRNAs targeted to the 
3’-UTR region of IGFBP-3. Predicated targest generated from  (A) 
TargetScanS and (B) PicTar software (*, highly conserved). 
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Figure 27:  miRNA expression levels in normal versus replicatively 
senescent cells.  HFL-1 cells at PD 6 and PD 48 were seeded at 60% 
confluency. Two days later RNA was isolated and miRNA levels were 
evaluated in triplicate, n=3. miRNA RNU6B was used as loading control. (*, 
p≤0.05) miR-19a is significantly decreased in senescent HFL-1 cells. 
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labeled negative control for 12 hours before media was replaced with serum-free media 
for an additional 48 hours. mRNA expression measured by qRT-PCR indicated almost 
25-fold increase in miR19a expression (Figure 28A). Interestingly, IGFBP-3 mRNA 
expression was significantly decreased by nearly 30% compared to controls (Figure 
28B).   The secretion of IGFBP-3 protein was analyzed by western blot following culture 
media collection (Figure 28C). Taken together, the data supports miR-19a can suppress 
IGFBP-3 expression and appears to be downregulated in replicatively senescent cells 
where IGFBP-3 expression is significantly upregulated.   The next possible experiment 
to analyze the regulation of mir-19a on IGFBP-3-induced senescence would be to 
evaluate if constitutively expressed mir-19a could significantly suppress IGFBP-3 
inhibiting replicative senescence. Furthermore, can mir-19a expression inhibit IGFBP-3-
induced senescence in early passage fibroblasts? 
 
4.2.3 IGFBP-3R signaling in IGFBP-3-induced senescence 
IGFBP-3 has long been studied to have IGF-independent biological functions, 
although the mechanism involved in independent effects are largely unknown. 
Furthermore, IGFBP-3 IGF-independent effects appear to be dependent on cellular 
localization and cell type, further complicating our understanding. Our lab has recently 
reported the identification a new cell death receptor, IGFBP-3R, which is a single-span 
membrane protein that binds IGFBP-3 specifically, and no other IGFBP species in 
breast cancer (MDA231) and prostate cancer cells (M12) (Ingermann, et al.,2010).  The 
study concluded IGFBP-3/IGFBP-3R axis is impaired in breast and prostate cancer,  
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Figure 28: Transfection of pre-miR-19a in HFL-1 (PD 45). HFL-1 cells were 
seeded at 70% confluency.  Cells were transfected with either FAM-labeled 
control miRNA or pre miR19a for 12 hours in serum containing. Media was 
replaced with serum free media and cells were incubated for an additional 48 
hours before RNA isolation or cell harvesting. (A) qRT-PCR analysis of miR-
19a, using RNU86 as an internal control and IGFBP-3 expression, using 
GAPDH as an internal control levels,n=2. (C) Proteins were analyzed by 
western blot, -tubulin was used as a loading control. IGFBP-3 secretion was 
measured from culture media. Statistical significance was noted between the 
control and treated samples. (*, p≤0.05) miR-19a suppression IGFBP-3 
expression.    
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supporting previous data for the anti-proliferative effect of IGFBP-3 in cancer 
cells (Ingermann, et al., 2010).  Furthermore, IGFBP-3R mediates IGFBP-3 induced 
capase-8-dependent apoptosis. Suppression of IGFBP-3R prior to overexpressing 
IGFBP-3 inhibits the proapoptotic effect of IGFBP-3 in MDA231 cells (Ingermann, et al., 
2010).   This data established a novel IGFBP-3 binding partner that plays an essential 
role in IGFBP-3 signaling.  The role of IGFBP-3R in normal cells has yet to bee 
investigated, until now.  
The ability of the IGFBP-3/IGFBP-3R axis to induce or maintain senescence is 
likely relevance to aging.  The principal function of IGFBP-3 is to transport IGFs in order 
to protect them from rapid degradation until they can bind to IGF receptors and 
modulate downstream IGF/IGFR signaling.  However, reports have shown no significant 
correlation between aged human species and the ratio of IGF and IGFBP-3 (Fontana, 
Let al., 2008), contradicting what has previously been reported in rodent studies 
(Shimokawa, et al., 2008), which studies suggest IGFBP-3 upregulation in aged tissues 
and cells may be IGF-independent.   
The data generated thus far suggest that IGFBP-3/IGFBP-3R axis is an essential 
pathway regulating senescence replicative and prematurely induced senescence, 
possibly through ROS production and activation p38 MAPK signaling. With significant 
expression of IGFBP-3R at PD24 in HFL-1 cells, we employed two different constructs 
of shRNAs against the novel IGFBP-3R. Knock-down of IGFBP-3R was analyzed by 
real time-PCR and western blot (Figure 29A and 29B, respectively). An almost 60% and 
80% suppression was achieved using IGFBP-3 shRNA 1-3 and 5-3 constructs,  
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Figure 29: Suppression of IGFBP-3R using viral supernatant. Presecenct cells 
HFL-1 (PD 24) cells seeded at 50% confluency and exposed to pSRN IGFBP-3R 
siRNA 1-3 or 5-3 or empty vector retrovirus supernatant for 24 hours before fresh 
serum containing media was added for an additional 24 hours. Infection was 
repeated with a second before RNA was isolated and cell lysates were harvested. 
(A) qRT-PCR analys is IGFBP-3R mRNA expression, GAPDH was used a loading 
control. (B) Western blot analysis of IGFBP-3R expression, -tubulin was used a 
loading control and densitometric measurements were quanitified.IGFBP-3R 
shRNA (1-3) and (5-3) plasmids suppress endogenous IGFBP-3R expression.  
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respectively. IGFBP-3R protein levels did not have as large a decrease when 
analyzed by western blot but still had significant decrease of almost 40% for each 
shRNA compared to control (Figure 30B). 
HFL-1 (PD24) cells were subjected to IGFBP-3R shRNA or empty vector virus 
supernatant for 24 hours before fresh serum containing media was added for an 
additional 24 hours. A second infection was performed for an additional 24 hours. Cells 
were infected with IGFBP-3 adenovirus for 2 days followed by a third shRNA infection 
for 24 hours. Cells were treated with second IGFBP-3 adenovirus infection and 
incubated for an additional 48 hours. The number of SA--gal positive cells were 
counted in 3 fields of 100 cells per field, n=2 (Figure 30A). IGFBP-3 overexpressed cells 
had increased SA-b-gal positive cells, however in the effects of IGFBP-3 were inhibited 
in the presence of IGFBP-3R shRNA. Furthermore, we evaluated the downstream 
IGFBP-3-upregulated senescence associated genes p21 (Figure 30B). IGFBP-3R 
suppression does not completely knockdown IGFBP-3R signaling, as indicated by only 
a moderate decrease in protein levels. The effects of IGFBP-3 overexpression were not 
completely inhibited by IGFBP-3R shRNA, however, this may be explained a significant 
ligand to receptor ratio.  As IGFBP-3R overexpression alone can induce premature 
senescence in early passage HFL-1 cells, this may be possible as early passage cells 
have low levels of endogenous IGFBP-3. To further evaluate the essential function of 
IGFBP-3R in IGFBP-3-induced senescence, a complete knockdown of IGFBP-3R 
expression will need to be achieved, to investigate if IGFBP-3 can still signal 
senescence.    
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Figure 30: Suppression of IGFBP-3R using shRNA virus 
supernatant. Presecenct cells HFL-1 (PD 24) cells seeded at 50% 
confluency  and exposed to pSRN IGFBP-3R siRNA 1-3 or 5-3 or 
empty vector retrovirus supernatant for 24 hours before fresh serum 
containing media was added for an additional 24 hours. A second 
infection was performed for an additional 24 hours. Cells were IGFBP-
3 adenoviurs infected for 2 days followed by a third shRNa infection 
for 24 hours. Cells were treated with second IGFBP-3 adenovirus 
infection. 2 days later cells were either fixed an stained for SA-gal 
(A) activity or lysates were harvested for protein analysis, -tubulin 
used as loading control (B). IGFBP-3R shRNA can significnatly 
inhibited IGFPB-3-induced increases in SA--gal positive cells and SA 
gene, p21. (*, p≤0.05)  
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4.3 Discussion 
This study identifies IGFBP-3/IGFBP-3R-induced senescence can cause an 
upregulation of ROS production and activation of downstream SA genes.  Suppression 
of ROS accumulation by GSH inhibits IGFBP-3/R-induced senescence and downstream 
p38 MAPK signaling. Furthermore, IGFBP-3-induced senescence can also be inhibited 
by suppression p38 MAPK activation. For this first time, we have investigated the role of 
newly identified IGFBP-3R in regulating senescence. IGFBP-3R overexpression can 
induce senescence similar; however suppression of endogenous IGFBP-3R inhibits 
IGFBP-3-induced senescence. This data suggests IGFBP-3R axis is an essential 
mediator in the IGFBP-3 senescence signaling cascade. As IGFBP-3 is known to be 
upregulated we investigated a possible regulator targeted responsible for this 
upregulation. The expression of miR-19a is significantly downregulated in senescent in 
comparison early passage HFL-1 cells and inversely to IGFBP-3 expression. 
Interestingly, overexpressing miR-19a in senescent cells suppresses the expression of 
IGFBP-3 at both mRNA and protein levels, suggesting a role in regulating  IGFBP-3 
expression.  We provide sufficient evidence to propose that IGFBP-3/IGFBP-3R axis is 
upregulated in senescence and this upregulation can induces senescence via ROS 
accumulation and p38 MAPK activation.  Figure 31 presents a model proposing IGFBP-
3 can signaling IGFBP-3R induce ROS accumulation which in turn activates p38 MAPK 
signaling and downstream senescence associated gene expression, ultimately leading 
to senescence.  
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Figure 31: IGFBP-3/IGFBP-3R axis signaling in cellular senescence.  IGFBP-
3 and IGFBP-3R expression is upregulated in replicative and prematurely induced 
senescence.  IGFBP-3 upregulation induces ROS accumulation which activates 
p38 signaling and other downstream senescence associated genes. Suppression 
of endogenous IGFBP-3R, ROS accumulation and p38 phosphorylation inhibits 
IGFBP-3-induced senescence.   
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Chapter 5 
Discussion 
 
 
5.1 Preface 
 Aging presents a worldwide social and financial challenge, and by the year 2050, 
over two billion people will be at least 65 year of age (Lutz, et al., 1997). Human aging is 
very often related to variety of diseases including but not limited to cardiovascular 
disorders, cancer, diabetes, and muscular degeneration. During this century the effects 
of aging are estimated to be a major global health care challenge (Mills, 1998).  
Understanding the mechanisms of aging are necessary to provide insights into the 
pathogenesis of a range of age-associated diseases and more importantly, potential 
interventions.  Aging has long been studied in a wide range of species leading to the 
identification of longevity genes, tumor suppressive genes, and multiple pathways of 
cellular aging, also termed senescence (Patridge, et al., 2002; and Martin, 2005).  
Numerous molecular pathways have been proposed to contribute to aging, however the 
complex nature of genetics, molecular and cellular signaling, have prevented a detailed 
understanding of the aging process.  One of the most widely studied mechanisms of 
aging was proposed nearly 50 years ago with the identification of cellular senescence.  
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5.2 IGFBP-3/IGFBP-3R signaling in senescence  
 Aging is an evolutionary byproduct of millions of years of selection for 
reproductive success.  The aging of organisms occurs at virtually every level of 
complexity, from cells to tissue to organ systems. Two consistent interventions used to 
increase lifespan in both invertebrates and vertebrate animal systems are caloric 
restriction and suppression of GH/IGF/insulin axis. Animal models have established IGF 
signaling pathway as a pivotal regulator of aging in rodents and invertebrates 
(Berryman, et al.,2008). GH/IGF signaling cascade, or homologous pathways in other 
species, are evolutionarily conserved and undoubtedly affect the basic phenotypic 
characteristics of aging and longevity in a wide range of organisms.   In humans 
specifically, decreased GH/IGF activity is linked to increased morbidity in adulthood and 
increased risk of age-associated pathologies including cardiovascular disease, diabetes 
and neurordegenerative disease (Perrini, 2010).  However, the understanding of IGF 
and aging becomes more complex as there appears to be a tightly controlled regulation 
and maintenance of IGF to prevent disease, as IGF activity suppression and 
overexpression can drastically alter the onset of age-associated diseases and overall 
longevity.   IGFBP-3 is the major binding protein involved in IGF signaling; however, 
IGFBP-3 homology is not observed across species identified to have GH/IGF conserved 
signaling. Therefore, despite being a key regulatory protein in IGF function, IGFBP-3’s 
role in aging may be different than what has previously been described in regards to 
IGF signaling cascade and aging.  Although IGFBP-3 primarily functions to regulate IGF 
signaling, IGFBP-3 has distinct IGF-independent biological functions.  Cell growth 
inhibition, via apoptosis, has long been viewed as the primary physiological response to 
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overexpression of IGFBP-3 in various cancer cell lines, independent of IGF. A role of 
IGFBP-3 independent of IGF has yet to be examined in normal cells.  
 Our laboratory has recently published the identification of a novel IGFBP-3R, 
which characterizes and describes how IGFBP-3 effects can be mediated independent 
of IGF (Ingermann, et al., 2010).  IGFBP-3R is described as a single-span membrane 
cell death receptor that binds specifically to IGFBP3 and no other IGFBPs (Ingermann, 
et al., 2010). By examining the IGFBP-3/IGFBP-3R axis in a variety of breast and 
prostate cancer cell lines, the published data demonstrated an anti-tumor effect 
mediated by caspase-8-dependent apoptosis. Furthermore, IGFBP-3 effects were 
dependent on IGFBP-3R, as suppression of IGFBP-3 prevented IGFBP-3-induced 
apoptosis (Ingermann, et al., 2010).   The biological function of IGFBP-3R has been 
primarily characterized in various cancer cells lines.  The published data regarding 
IGFBP-3R brings to the forefront a potential mechanism by which IGFBP-3 can mediate 
senescence and in aging, independent of IGF signaling.  
The link between human aging and cellular senescence has long been studied 
and confirmed to be highly correlated. Evidence of increased accumulation of 
senescence cells in aged patients and from patient exposed to stress stimuli such as 
oxidative-stress and UV exposure suggest a highly plausible hypothesis that states 
cellular senescence contributes to biological organismal aging. By identifying how 
senescence is induced and the effects of accumulating senescence cells in vivo will 
provide tremendous insight into biological aging, age-associated diseases and possibly, 
therapeutic interventions.  
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Interestingly several groups have been reported IGFBP-3 mRNA and protein 
expression to be upregulated in both replicative and premature-induced senescence, in 
vivo and in vitro (Debacq-Chainiaux, et al., 2008; Goldstein et al., 1993; Kim et al., 
2007).  However, there are no proposed mechanisms for how IGFBP-3 is being 
upregulated or what may be the consequences of this upregulation.  In this current 
study, we aimed to characterize and identify the role if IGFBP-3 and its newly identified 
IGFBP-3R in cellular senescence in order to understand their roles in biological aging.  
We initially developed a model of replicative senescence induced by serial 
passage of HFL-1 cells.  Our model clearly demonstrates upregulation of senescence 
associated genes, at both the mRNA and protein levels during replicative senescence. 
Furthermore, p38 MAPK signaling appears to be activated as indicated by increased 
phosphorylation of p38. We show both IGFBP-3 and its novel receptor, IGFBP-3R, have 
significantly increased mRNA and protein expression levels which were correlated to 
decreased cell replicative capacity.  
As we identified an upregulation of IGFBP-3 and IGFBP-3R in replicative 
senescence, we aimed to determine possible mechanisms for upregulation and 
signaling induced by IGFBP-3 upregulation. In order to examine the role of IGFBP-3, we 
evaluated the effects of overexpressing IGFBP-3 in young fibroblasts and used a 
mutant IGFBP-3GGG to establish IGF-independent effects.  Overexpression of IGFBP-3, 
IGFBP-3GGG and IGFBP-3R in early passage fibroblasts (PD4) induces senescence 
morphological changes, increased SA--gal staining and increasing mRNA and protein 
levels of senescence associated genes, p16, p53 and p21.  Furthermore, using a 
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mutant form of IGFBP-3 (IGFBP-3GGG), which has lost binding affinity to IGFs but 
retains IGF-R binding capability, confirms IGF-1-independent effects. Overexpression of 
IGFBP-3 or IGFBP-3R increased ROS accumulation and p38 MAPK activity.  This data 
demonstrated that overexpression of IGFBP-3, its mutant or IGFBP-3R triggers 
premature senescence of early passage normal fibroblasts, implicating a crucial role of 
IGFBP-3 in the induction of senescence.   
The significance of IGFBP-3 expression in replicative senescence was further 
evaluated, as endogenous suppression of IGFBP-3 prohibited presenescent cells from 
entering a senescent state.  Next, fibroblasts derived patients with Werner syndrome 
which have a limited in vitro replicative lifespan, clearly show upregulated IGFBP-3 
expression.  We demonstrated that suppression of endogenous IGFBP-3 protein using 
shRNA techniques reversed the senescence phenotype and increased the proliferation 
potential compared to non-treated cells. Endogenous suppression of IGFBP-3 in HFL-1 
and WS cells illustrates the impact of this signaling pathway and generates confidence 
that IGFBP-3 may be explored as a possible therapeutic target.  
Shortened telomeres and/or decreased telomerase activity were originally 
described as the primary signaling pathway for replicative senescence induction. The 
capability of cells to undergo premature senescence highlighted a novel hypothesis that 
senescence was not solely triggered by replicative exhaustion and subsequent telomere 
shortening.  In our cell system, we demonstrated IGFBP-3/IGFBP-3R could induce 
premature senescence in the presence of telomerase. This data demonstrates IGFBP-
3/R-induced senescence cannot be inhibited by telomerase activity, suggesting the 
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signaling pathway of IGFBP-3/R axis is different than that triggered by significantly 
decreased telomere length.  
Our published data clearly demonstrates IGFBP-3R plays an integral role in 
IGFBP-3 induced apoptosis in cancer cells; however, we demonstrate for the first time 
that IGFBP-3R is also vital to IGFBP-3 signaling in normal cells. To determine if IGFBP-
3 required IGFBP-3R signaling, we tested the effects of suppressing endogenous 
IGFBP-3R expression. Suppression IGFBP-3R followed by overexpression of IGFBP-3 
decreased the number of cells that underwent senescence; however senescence was 
not completely abrogated.  The inability of IGFBP-3R suppression to completely inhibit 
IGFBP-3-induced senescence suggests IGFBP-3 can signal other pathways or more 
specifically internalized. IGFBP-3 is known to be internalized via distinct endocytosis 
mediated caveolin-1 (Lee, et al., 2004). IGFBP-3 possesses a caveolin-scaffolding 
domain consensus sequence at the C-terminal end (Lee, et al., 2004).   It has been 
widely demonstrated that caveolin-1 acts as an antiprolifierative protein, as its 
overexpression in mouse embryonic fibroblasts induces G1 phase cell cycle arrest and 
activates p53/p21 signaling (Galbiati, et al., 2001).  Given the role of caveloin-1 in 
regulating cell cycle arrest and that IGFBP-3 internalization requiring caveloin-1, tthese 
results suggest IGFBP-3 may be able to elicit a senescence response independent of 
IGFBP-3R signaling and confirms the extensiveness by which IGFBP-3 can induce cell 
growth inhibition.   Although it appears that IGFBP-3/IGFBP-3R axis signaling is 
complex, inhibition of senescence can be achieved by suppression of endogenous 
IGFBP-3 or IGFBP-3R expression. All together, our results indicated that IGFBP-
3/IGFBP-3R axis is a key regulator in cellular senescence. 
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 To better understand how IGFBP-3 functions in senescence signaling, we aimed 
to examine what upregulates its expression in senescent cells and/or what inhibits its 
expression in young replicating cells.  The recent emergence of functional studies 
regarding miRNAs brought forward a novel opportunity to investigate possible miRNA 
regulation of IGFBP-3.  miRNA regulation of gene activity may provide crucial 
information towards unraveling a specific role for genes involved in senescence 
signaling pathways. Of the 4 highly conserved predicted miRNA targets for IGFBP-3, 
miR-19a appeared to be most differentially expressed compared to IGFBP-3 
expression. We have demonstrated that miR-19a is downregulated in senescence cells, 
which is inversely correlated with IGFBP-3 expression. Upregulating miR-19a 
expression by pre-miR-19a transfection caused decreased IGFBP-3 mRNA and protein 
expression.  One group has reported that miR-19a can attenuate the progression of 
endothelial cells from G1 to S phase, and subsequently induce senescence (Qin, et al., 
2009). Furthermore, they demonstrate miR-19a appears to suppress cyclin D1 
expression, which is a key regulator of cell cycle progression. Our findings, taken 
together with published data, suggest miR-19a may be vital in regulating IGFBP-3 
suppression, thereby inhibiting its growth inhibitory effects in young early passage cells. 
Ultimately, this supports the complexity of senescence and more importantly how 
senescence phenotype and gene expression may not be indistinguishable from various 
senescence stimuli, but the role and signaling pathways of regulator genes is diverse.  
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5.3 ROS upregulation in IGFBP-3/IGFBP-3R-induced senescence 
 ROS are oxygen free radicals that are highly reactive toward various cellular 
contents including DNA, protein and lipids. ROS are generated in various biological 
systems and known to be important determinants in regulating cell signaling pathways 
involved in proliferation, apoptosis and senescence (Gamaley, 1999; Powis, 1995). 
Evaluation of ROS levels, oxidation of macromolecules, and a shift in cellular redox 
status suggest ROS production increases with age (Kregel, et al., 2007). Although 
previous studies show oxidative stress-induced senescence increases IGFBP-3 
secretion, to date there has been no evidence to suggest IGFBP-3 could signal 
increased ROS production.  The cellular processes that produce ROS are vast and 
complex and the downstream pathways activated by ROS are even more complicated 
and numerous. Under normal conditions ROS production is essential for normal cellular 
functions.   The damaging effects of ROS occur with increased production and/or 
increased accumulation due to decreased antioxidant effects. One of the primary 
pathways signaled by ROS production is p53.  p53 can be signaled by DNA damage 
induced by ROS or other oxidative stress stimuli initiated by increased ROS production.  
Interestingly, it has been reported that p53-induced senescence can be inhibited by 
silencing IGFBP-3, and furthermore there is an inverse correlation between IGFBP-3 
and Foxo3a in this system (Kim, et al., 2004). Foxo3a is known to be involved in the 
upregulation of catalase and MnSOD, two enzymes involved in the elimination of toxic 
ROS (Czymai, et al., 2010). Foxo3a is a member of FOXO family of forkhead 
transcription factors regulated by PI3K/Akt signaling pathway. (Kim, et al., 2004) 
PI3K/Akt signaling is regulated by insulin and IGF signaling pathways and known to 
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contribute to life span in mammals. Foxo3a protein is known to be lower in aged HDFs 
cells compared to younger cells (Kim, et al., 2004).  This regulation of Foxo3a by IGF 
signaling brings forth the significance of maintaining a tight balance of IGF regulation.  
As downregulation of Foxo3a protein is known to accelerate senescence, the inverse 
relationship between IGFBP-3 and Foxo3a may further support our hypothesis between 
ROS upregulation and IGFBP-3 induced senescence (Kim, et al., 2005).  
 
5.4 p38 MAPK signaling in IGFBP-3/IGFBP-3R-induced senescence 
 As we have demonstrated IGFBP-3 and IGFBP-3R induced senescence can 
signal p38 activation by ROS accumulation, the next step will be to investigate how 
ROS signals p38 phosphorylation.  As discussed in the introduction, the Trx-ASK1 
complex is known to regulate senescence by activation of p38 MAPK; therefore, it might 
be essential to characterize the Trx-ASK1 complex in our cell system.  ROS has been 
shown to be involved in Akt signaling, which can then phosphorylate apoptosis signal-
regulatory proteins (ASK1) (Kim, 2001; Mochizuki,  2006).  Recently, ASK1 has been 
indentified to be complexed with thioredoxin1 (Trx1), and upon ROS oxidation, ASK1 
can phosphorylate p38 MAPK, thereby inducing downstream senescence transcription 
factors.  
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5.5 Werner Syndrome and IGFBP-3 
 There are two canonical progeroid disorders, Werner’s Syndrome and 
Hutchinson-Gilford progeriod syndrome (Cox and Faragher, 2008).  These disorders 
recapitulate rapid phenotypic aging, which occurswell before normal aging.  Advancing 
our understanding of the pathogenesis of these disorders must be examined in parallel, 
as this will aid in understanding the normal aging process (Cox and Faragher, 2008).  
Mutations of specific genes that characterize and define each progeriod syndrome have 
been identified and well studied to participate in a verity of pathways and processes 
(Cox and Faragher, 2008).  It is important to note that although the mutated gene 
products contribute to in vital biological processes, their participation may not be the 
pivotal player,by which the accelerated aging pathologies are derived.  These disorders 
demonstrate the integral relationship between genotype and phenotype and 
furthermore, the extensiveness and complexity between aging and senescence.   
 To date there has been no investigation into the role of IGFBP-3 protein in 
people having Werner syndrome, despite reports of endogenous upregulation.  We 
demonstrate that the senescence phenotype observed from WS derived fibroblasts 
could be reversed by suppression of endogenous IGFBP-3 similar to that observed 
when WS cells were exposed to long-term treatment with SB203580 (Davis, et al., 
2005). Although previous studies demonstrate that blocking p38 inhibits only p21, 
expression, we demonstrate a decrease in p53 and p16 in addition to p21, suggesting 
that IGFBP-3 may convered on p21 expression directly related to p38 signaling but also 
influce pathways mediated directly by p53 and p16.  From a clinical perspective, the 
significance of IGFBP-3 to regulate in vivo aging process has not been determined.  
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The identification of p38 MAPK as a potential therapeutic target in WS patients 
suggests IGFBP-3/IGFBP-3R inhibition in this system may also have beneficial effects.   
Although IGFBP-3 appears to be important for inducing apoptosis in cancer cells, 
the advantages or disadvantages of upregulated IGFBP-3 expression in normal cells 
and tissues needs to be explored.  We hypothesize that the balance between 
upregulated IGFBP-3/IGFBP-3R axis signaling is tightly controlled.  By all accounts, 
cells enter into a senescent state to prevent the replication of damaged cells, and as 
result senescence is classified as a tumor suppressive mechanism.  In this study we 
have demonstrated for the first time the effects of overexpressing IGFBP-3/IGFBP-3R 
signaling in normal diploid fibroblast, and the effects of suppressing endogenous 
signaling. It would be advantageous to explore the tight balance between upregulation 
of IGFBP-3/IGFBP-3R signaling that can induce senescence in normal cells but induce 
proapoptotic signaling in cancer cells.  The complexity of this pathway suggests that the 
response elicited by this signaling axis may be dependent on the molecular and genetic 
composition of cells.  
   
5.6 Perspective 
 In summary, the results presented here demonstrate a novel role for the 
upregulation of IGFBP-3/IGFBP-R signaling in both replicative and premature-induced 
senescence. IGFBP-3/IGFBP-R can induce premature senescence by increasing 
intracellular ROS production, activating downstream p38 MAPK, and subsequently 
inducing senescence-associated genes, all of which leads to cell growth arrest in 
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normal cells.  Inhibition of ROS inhibits IGFBP-3/IGFBP-3R-induced senescence. p38 
MAPK signaling is activated downstream of ROS production and may be signaling 
downstream senescence-associated genes for upregulation. Suppression of 
endogenous IGFBP-3 expression can inhibit replicative senescence induction and 
furthermore, reverse the senescence phenotype typical of Werner Syndrome 
fibroblasts. The novel IGFBP-3R also plays a vital role in the signaling of IGFBP-3 as 
IGFBP-3R shRNA can inhibit IGFBP-3- induced senescence.   
The last 20 years has produced an exponential rise in the understanding of 
cellular and molecular aging.  The mechanisms by which progeriod syndromes are 
caused may have little to no relevance to normal aging; however, this suggest that the 
most likely cause of aging phenotype is cellular senescence.  The aging of organisms 
occurs at virtually every level of complexity, from cells to tissue to organ systems. These 
studies address a critical, emerging field of IGFBP-3’s role in the signaling of cellular 
senescence. The ability of IGFBP-3 to induced senescence is of much relevance to 
unraveling organismal aging, and we have clearly demonstrated the IGFBP-3/IGFBP-
3R axis plays an essential role in cellular senescence (Figure 31). 
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